| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.90e-07 | 127 | 153 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | DDX12P ERCC6L CHD7 FANCM DICER1 DDX11 BPTF TDP1 MBD4 DDX11L8 XRCC6 TOP2B | 8.69e-07 | 262 | 153 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.75e-06 | 4 | 153 | 3 | GO:0045142 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX12P DNAH10 ERCC6L MYH7B CHD7 FANCM DICER1 DNAH1 DDX11 ACSL4 BPTF KIF5C MORC3 DDX11L8 XRCC6 TOP2B | 2.04e-05 | 614 | 153 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | 3.02e-05 | 158 | 153 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 6.96e-05 | 11 | 153 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FMR1 MYLK MAP7D3 NRCAM MAP1B VEZT MYH7B SYNE1 COBLL1 PTK2 CEP350 DST BRCA2 SYNE2 MICAL3 KIF5C GNAS CCDC181 MAP4K4 NEXN TTLL13 | 1.01e-04 | 1099 | 153 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.13e-04 | 62 | 153 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 1.51e-04 | 14 | 153 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | chromatin binding | SATB2 DDX12P FMR1 CHAF1A MSL1 CHD7 APP FANCM DDX11 TNRC18 CTCF CBX5 SUPT16H DDX11L8 CUX1 TOP2B | 1.80e-04 | 739 | 153 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA replication origin binding | 3.31e-04 | 18 | 153 | 3 | GO:0003688 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX12P ERCC6L CHD7 FANCM DICER1 DDX11 BPTF SEPSECS RTCA TDP1 MBD4 DDX11L8 XRCC6 TOP2B | 4.51e-04 | 645 | 153 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | tubulin binding | FMR1 MAP7D3 MAP1B CEP350 DST BRCA2 KIF5C GNAS CCDC181 MAP4K4 TTLL13 | 4.73e-04 | 428 | 153 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 5.75e-04 | 5 | 153 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 5.75e-04 | 5 | 153 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.88e-04 | 134 | 153 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | LRR domain binding | 6.10e-04 | 22 | 153 | 3 | GO:0030275 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 8.57e-04 | 6 | 153 | 2 | GO:0008349 | |
| GeneOntologyBiologicalProcess | chromatin organization | MORC1 SATB2 ARID4B ERCC6L ARID4A CHAF1A DAPK3 MSL1 ZDBF2 CHD7 APP USP16 DICER1 PRDM2 DDX11 RTF1 BPTF BRCA2 CTCF CBX5 SUPT16H HTATSF1 GNAS | 1.37e-07 | 896 | 150 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | microtubule-based transport | FMR1 MAP1B NEK10 DYNC2I1 APP DNAH1 DST SYNE2 KATNIP KIF5C MGARP PCM1 | 3.45e-07 | 253 | 150 | 12 | GO:0099111 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MORC1 SATB2 ARID4B ERCC6L ARID4A CHAF1A DAPK3 MSL1 ZDBF2 CHD7 APP USP16 DICER1 PRDM2 DDX11 RTF1 BPTF BRCA2 CTCF CBX5 SUPT16H HTATSF1 GNAS | 9.21e-07 | 999 | 150 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | epigenetic programming of gene expression | 1.45e-06 | 49 | 150 | 6 | GO:0043045 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MORC1 SATB2 ARID4B ERCC6L ARID4A CHAF1A MSL1 ZDBF2 CHD7 APP USP16 DICER1 PRDM2 BPTF BRCA2 CTCF CBX5 SUPT16H GNAS | 1.91e-06 | 741 | 150 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | microtubule-based process | FMR1 MAP7D3 DNAH10 MAP1B NEK10 DYNC2I1 APP DICER1 PTK2 DNAH1 CEP350 FSIP2 CEP68 DST CEP120 BRCA2 SYNE2 KATNIP KIF5C MGARP HYDIN PCM1 TTLL13 | 2.44e-06 | 1058 | 150 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule-based movement | FMR1 DNAH10 MAP1B NEK10 DYNC2I1 APP DNAH1 FSIP2 DST SYNE2 KATNIP KIF5C MGARP HYDIN PCM1 | 3.25e-06 | 493 | 150 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | nuclear migration | 4.47e-06 | 34 | 150 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | genomic imprinting | 5.18e-06 | 35 | 150 | 5 | GO:0071514 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 1.43e-05 | 197 | 150 | 9 | GO:0010970 | |
| GeneOntologyBiologicalProcess | nucleus localization | 1.64e-05 | 44 | 150 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | DNA repair | DDX12P FMR1 CHAF1A FANCM DDX11 BRCA2 SUPT16H HTATSF1 SPIDR HERC2 CDC5L TDP1 MBD4 DDX11L8 XRCC6 TOP2B | 2.07e-05 | 648 | 150 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA damage response | DDX12P FMR1 HIPK1 CHAF1A FANCM USP16 DDX11 BRCA2 CBX5 SUPT16H HTATSF1 SPDYA SPIDR HERC2 CDC5L TDP1 MBD4 DDX11L8 XRCC6 TOP2B | 2.15e-05 | 959 | 150 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TNIK NRCAM MAP1B SYNE1 MINK1 LAMA2 NCAM1 BCAN APP DICER1 PTK2 DST KIF5C RIMS2 MAP4K4 NEXN CUX1 TOP2B | 2.21e-05 | 802 | 150 | 18 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK NRCAM MAP1B SYNE1 MINK1 LAMA2 NCAM1 BCAN APP DICER1 PTK2 DST KIF5C RIMS2 MAP4K4 NEXN CUX1 TOP2B | 2.91e-05 | 819 | 150 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK NRCAM MAP1B SYNE1 MINK1 LAMA2 NCAM1 BCAN APP DICER1 PTK2 DST KIF5C RIMS2 MAP4K4 NEXN CUX1 TOP2B | 3.25e-05 | 826 | 150 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 4.09e-05 | 225 | 150 | 9 | GO:0030705 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TNIK NRCAM MAP1B SYNE1 MINK1 LAMA2 NCAM1 DAPK3 BCAN APP DICER1 PTK2 STRIP1 SIDT2 DST PDZD8 KIF5C RIMS2 MAP4K4 NEXN CUX1 TOP2B | 5.31e-05 | 1194 | 150 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 5.96e-05 | 11 | 150 | 3 | GO:0034085 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 6.44e-05 | 94 | 150 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TNIK FMR1 MYLK SYNE1 MINK1 DYNC2I1 DNAH1 CEP350 FSIP2 CEP120 SYNE2 SNX10 MAP4K4 HYDIN PCM1 | 1.14e-04 | 670 | 150 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | TNIK FMR1 MYLK SYNE1 MINK1 DYNC2I1 DNAH1 CEP350 FSIP2 CEP120 SYNE2 SNX10 MAP4K4 HYDIN PCM1 | 1.45e-04 | 685 | 150 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | neuron projection development | TNIK FMR1 NRCAM MAP1B SYNE1 MINK1 LAMA2 NCAM1 BCAN APP DICER1 PTK2 ACSL4 DST RTCA KIF5C RIMS2 MGARP MAP4K4 NEXN CUX1 TOP2B | 1.54e-04 | 1285 | 150 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP7D3 MAP1B DICER1 PTK2 DNAH1 CEP350 FSIP2 CEP68 DST CEP120 BRCA2 SYNE2 HYDIN PCM1 TTLL13 | 2.49e-04 | 720 | 150 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 2.62e-04 | 78 | 150 | 5 | GO:0032508 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.12e-04 | 4 | 150 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | DDX12P FMR1 CHAF1A FANCM DICER1 DDX11 BRCA2 YLPM1 SUPT16H HTATSF1 SPDYA SPIDR HERC2 CDC5L TDP1 MBD4 DDX11L8 XRCC6 TOP2B | 3.26e-04 | 1081 | 150 | 19 | GO:0006259 |
| GeneOntologyBiologicalProcess | protein localization to organelle | TNIK RGPD8 FAM53A SYNE1 APP RYR2 CEP350 FSIP2 CEP68 BRCA2 CTCF SNX10 HTATSF1 SPDYA SPIDR MORC3 MGARP PCM1 RGPD5 | 3.65e-04 | 1091 | 150 | 19 | GO:0033365 |
| GeneOntologyBiologicalProcess | DNA geometric change | 4.13e-04 | 86 | 150 | 5 | GO:0032392 | |
| GeneOntologyBiologicalProcess | intracellular transport | CASC3 FMR1 RGPD8 MAP1B FAM53A SYNE1 DYNC2I1 APP PTK2 DST CEP120 UPF2 SYNE2 NEMF SNX10 KIF5C GNAS LRBA HERC2 RIMS2 MGARP PCM1 RGPD5 | 5.07e-04 | 1496 | 150 | 23 | GO:0046907 |
| GeneOntologyBiologicalProcess | brain development | DMXL2 NRCAM MINK1 NCAM1 BCAN CHD7 APP DICER1 BPTF CEP120 BRCA2 SYNE2 MGARP HYDIN TOP2B PCM1 | 5.32e-04 | 859 | 150 | 16 | GO:0007420 |
| GeneOntologyCellularComponent | nuclear envelope | CASC3 RGPD8 TEX2 SYNE1 APP RYR2 ATP1B4 TNRC18 MLIP DST CBX5 SYNE2 SPDYA PCM1 RGPD5 | 1.49e-05 | 560 | 152 | 15 | GO:0005635 |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 4.36e-05 | 10 | 152 | 3 | GO:0031390 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CASC3 SATB2 DDX12P ARID4B RGPD8 ARID4A SYNE1 PRPF6 FANCM DDX11 RTF1 BPTF UPF2 BRCA2 CBX5 SYNE2 SUPT16H HTATSF1 CDC5L THRAP3 DDX11L8 XRCC6 RGPD5 | 1.56e-04 | 1377 | 152 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | growth cone filopodium | 3.12e-04 | 4 | 152 | 2 | GO:1990812 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 4.55e-04 | 21 | 152 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | sarcolemma | 4.90e-04 | 190 | 152 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | centrosome | DDX12P HIPK1 PSMA1 ANKRD62 DYNC2I1 PTK2 DDX11 CEP350 CEP68 CEP120 BRCA2 CAPN7 SNX10 DDX11L8 PCM1 | 5.06e-04 | 770 | 152 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | axon | SLC12A6 FMR1 TRPA1 NRCAM MAP1B MINK1 NCAM1 BCAN APP PLEKHG5 DICER1 DST MPP4 KIF5C MGARP NEXN | 7.89e-04 | 891 | 152 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | chromatin | SATB2 DDX12P ARID4B ARID4A CHAF1A NKX2-3 MSL1 CHD7 FANCM WDR43 DDX11 BPTF ATP1B4 ZFHX4 CBX5 SUPT16H MORC3 MBD4 SMCR8 DDX11L8 CUX1 TOP2B | 1.06e-03 | 1480 | 152 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule organizing center | DDX12P HIPK1 PSMA1 ANKRD62 DYNC2I1 PTK2 DDX11 CEP350 CEP68 CEP120 BRCA2 CAPN7 SNX10 HERC2 DDX11L8 PCM1 | 1.09e-03 | 919 | 152 | 16 | GO:0005815 |
| MousePheno | abnormal cell nucleus morphology | DDX12P FMR1 RGPD8 ERCC6L CHAF1A DDX11 BRCA2 SYNE2 SPDYA DDX11L8 | 8.91e-06 | 184 | 131 | 10 | MP:0003111 |
| MousePheno | abnormal chromosome morphology | 2.39e-05 | 126 | 131 | 8 | MP:0003702 | |
| MousePheno | absent somites | 4.31e-05 | 42 | 131 | 5 | MP:0006386 | |
| MousePheno | increased allantois apoptosis | 4.35e-05 | 8 | 131 | 3 | MP:0003891 | |
| MousePheno | absent paraxial mesoderm | 6.48e-05 | 9 | 131 | 3 | MP:0012184 | |
| MousePheno | abnormal amniotic cavity morphology | 8.00e-05 | 25 | 131 | 4 | MP:0011199 | |
| MousePheno | peripheral nervous system degeneration | 9.20e-05 | 10 | 131 | 3 | MP:0000958 | |
| MousePheno | abnormal cingulate gyrus morphology | 9.20e-05 | 10 | 131 | 3 | MP:0004167 | |
| MousePheno | embryonic growth arrest | DDX12P ERCC6L CHAF1A CHD7 DICER1 DDX11 BPTF SEPSECS CEP120 CTCF YLPM1 DDX11L8 | 9.89e-05 | 346 | 131 | 12 | MP:0001730 |
| MousePheno | failure of somite differentiation | 1.01e-04 | 50 | 131 | 5 | MP:0001690 | |
| MousePheno | abnormal embryo development | CASC3 DDX12P RGPD8 ERCC6L VEZT CHAF1A DYNC2I1 DAPK3 CHD7 EXT2 DICER1 REXO1 PTK2 RYR2 STRIP1 FBXL5 DDX11 BPTF SEPSECS CEP120 BRCA2 CTCF YLPM1 MBD4 MAP4K4 DDX11L8 TOP2B | 1.46e-04 | 1370 | 131 | 27 | MP:0001672 |
| MousePheno | abnormal metencephalon morphology | TNIK SLC12A6 FMR1 NRCAM MAP1B NCAM1 CHD7 DST PDZD8 GNAS HERC2 TDP1 HYDIN | 1.58e-04 | 420 | 131 | 13 | MP:0000847 |
| MousePheno | decreased paraxial mesoderm size | 1.66e-04 | 12 | 131 | 3 | MP:0012183 | |
| MousePheno | abnormal intracellular organelle morphology | DDX12P FMR1 RGPD8 ERCC6L CHAF1A RYR2 DDX11 SIDT2 DST BRCA2 SYNE2 SPDYA HERC2 SMCR8 DDX11L8 | 1.81e-04 | 546 | 131 | 15 | MP:0014239 |
| MousePheno | abnormal cingulate cortex morphology | 2.15e-04 | 13 | 131 | 3 | MP:0020749 | |
| MousePheno | abnormal cerebellum morphology | TNIK SLC12A6 FMR1 NRCAM MAP1B NCAM1 CHD7 PDZD8 GNAS HERC2 TDP1 HYDIN | 2.93e-04 | 389 | 131 | 12 | MP:0000849 |
| Domain | CNH | 3.76e-06 | 14 | 150 | 4 | SM00036 | |
| Domain | CNH | 5.09e-06 | 15 | 150 | 4 | PF00780 | |
| Domain | CNH | 5.09e-06 | 15 | 150 | 4 | PS50219 | |
| Domain | CNH_dom | 5.09e-06 | 15 | 150 | 4 | IPR001180 | |
| Domain | RBB1NT | 6.41e-05 | 2 | 150 | 2 | PF08169 | |
| Domain | RBB1NT | 6.41e-05 | 2 | 150 | 2 | IPR012603 | |
| Domain | KCC1 | 6.41e-05 | 2 | 150 | 2 | IPR000622 | |
| Domain | Chromodomain-like | 1.21e-04 | 32 | 150 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.36e-04 | 33 | 150 | 4 | IPR000953 | |
| Domain | CHROMO | 1.36e-04 | 33 | 150 | 4 | SM00298 | |
| Domain | CH | 1.75e-04 | 65 | 150 | 5 | SM00033 | |
| Domain | hSH3 | 1.91e-04 | 3 | 150 | 2 | PF14603 | |
| Domain | hSH3 | 1.91e-04 | 3 | 150 | 2 | IPR029294 | |
| Domain | CH | 2.49e-04 | 70 | 150 | 5 | PF00307 | |
| Domain | - | 2.66e-04 | 71 | 150 | 5 | 1.10.418.10 | |
| Domain | CH | 3.03e-04 | 73 | 150 | 5 | PS50021 | |
| Domain | CH-domain | 3.43e-04 | 75 | 150 | 5 | IPR001715 | |
| Domain | KASH | 3.80e-04 | 4 | 150 | 2 | IPR012315 | |
| Domain | KASH | 3.80e-04 | 4 | 150 | 2 | PS51049 | |
| Domain | KASH | 3.80e-04 | 4 | 150 | 2 | SM01249 | |
| Domain | KASH | 3.80e-04 | 4 | 150 | 2 | PF10541 | |
| Domain | KCL_cotranspt | 3.80e-04 | 4 | 150 | 2 | IPR000076 | |
| Domain | HATPase_c | 4.48e-04 | 19 | 150 | 3 | PF02518 | |
| Domain | - | 5.24e-04 | 20 | 150 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 6.07e-04 | 21 | 150 | 3 | IPR003594 | |
| Domain | Laminin_domII | 6.31e-04 | 5 | 150 | 2 | IPR010307 | |
| Domain | Laminin_aI | 6.31e-04 | 5 | 150 | 2 | IPR009254 | |
| Domain | Laminin_I | 6.31e-04 | 5 | 150 | 2 | PF06008 | |
| Domain | Laminin_II | 6.31e-04 | 5 | 150 | 2 | PF06009 | |
| Domain | Spectrin | 7.99e-04 | 23 | 150 | 3 | PF00435 | |
| Domain | ACTININ_2 | 7.99e-04 | 23 | 150 | 3 | PS00020 | |
| Domain | ACTININ_1 | 7.99e-04 | 23 | 150 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.99e-04 | 23 | 150 | 3 | IPR001589 | |
| Domain | Tudor-knot | 9.41e-04 | 6 | 150 | 2 | PF11717 | |
| Domain | Tudor-knot | 9.41e-04 | 6 | 150 | 2 | IPR025995 | |
| Domain | zf-CW | 1.31e-03 | 7 | 150 | 2 | PF07496 | |
| Domain | ZF_CW | 1.31e-03 | 7 | 150 | 2 | PS51050 | |
| Domain | CUT | 1.31e-03 | 7 | 150 | 2 | PS51042 | |
| Domain | CUT | 1.31e-03 | 7 | 150 | 2 | PF02376 | |
| Domain | SLC12A_fam | 1.31e-03 | 7 | 150 | 2 | IPR004842 | |
| Domain | Znf_CW | 1.31e-03 | 7 | 150 | 2 | IPR011124 | |
| Domain | CUT_dom | 1.31e-03 | 7 | 150 | 2 | IPR003350 | |
| Domain | CUT | 1.31e-03 | 7 | 150 | 2 | SM01109 | |
| Domain | P-loop_NTPase | DNAH10 ERCC6L MYH7B CHD7 FANCM DICER1 DNAH1 DDX11 TRANK1 CTPS2 LRRIQ1 MPP4 YLPM1 KIF5C GNAS HYDIN | 1.32e-03 | 848 | 150 | 16 | IPR027417 |
| Domain | Kinase-like_dom | TNIK MYLK NEK10 HIPK1 MINK1 DAPK3 PTK2 PRDM2 DST MAP4K1 IRAK4 MAP4K4 | 1.45e-03 | 542 | 150 | 12 | IPR011009 |
| Domain | Spectrin_repeat | 1.59e-03 | 29 | 150 | 3 | IPR002017 | |
| Domain | SLC12_C | 1.74e-03 | 8 | 150 | 2 | IPR018491 | |
| Domain | SLC12 | 1.74e-03 | 8 | 150 | 2 | PF03522 | |
| Domain | SPEC | 2.12e-03 | 32 | 150 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.12e-03 | 32 | 150 | 3 | IPR018159 | |
| Domain | PH_dom-like | RGPD8 DOCK9 PLCD4 DGKH PLEKHG5 PTK2 PLEKHG1 SKAP1 LRBA RGPD5 | 2.36e-03 | 426 | 150 | 10 | IPR011993 |
| Domain | S_TKc | 2.50e-03 | 359 | 150 | 9 | SM00220 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.75e-03 | 35 | 150 | 3 | IPR002464 | |
| Domain | Grip | 3.36e-03 | 11 | 150 | 2 | SM00755 | |
| Domain | GRIP | 3.36e-03 | 11 | 150 | 2 | PF01465 | |
| Domain | DEAH_ATP_HELICASE | 3.49e-03 | 38 | 150 | 3 | PS00690 | |
| Domain | Protein_kinase_ATP_BS | 3.59e-03 | 379 | 150 | 9 | IPR017441 | |
| Domain | Pkinase | 3.71e-03 | 381 | 150 | 9 | PF00069 | |
| Domain | PROTEIN_KINASE_ATP | 4.01e-03 | 459 | 150 | 10 | PS00107 | |
| Domain | Ran_BP1 | 4.01e-03 | 12 | 150 | 2 | PF00638 | |
| Domain | RANBD1 | 4.01e-03 | 12 | 150 | 2 | PS50196 | |
| Domain | GRIP_dom | 4.01e-03 | 12 | 150 | 2 | IPR000237 | |
| Domain | GRIP | 4.01e-03 | 12 | 150 | 2 | PS50913 | |
| Domain | RanBD | 4.72e-03 | 13 | 150 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 4.72e-03 | 13 | 150 | 2 | IPR000156 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.47e-03 | 14 | 150 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.47e-03 | 14 | 150 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.47e-03 | 14 | 150 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.47e-03 | 14 | 150 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.47e-03 | 14 | 150 | 2 | IPR011704 | |
| Domain | MT | 5.47e-03 | 14 | 150 | 2 | PF12777 | |
| Domain | AAA_8 | 5.47e-03 | 14 | 150 | 2 | PF12780 | |
| Domain | AAA_5 | 5.47e-03 | 14 | 150 | 2 | PF07728 | |
| Domain | Prot_kinase_dom | 6.20e-03 | 489 | 150 | 10 | IPR000719 | |
| Domain | DHC_fam | 6.28e-03 | 15 | 150 | 2 | IPR026983 | |
| Domain | - | 6.28e-03 | 15 | 150 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 6.28e-03 | 15 | 150 | 2 | SM00501 | |
| Domain | ARID_dom | 6.28e-03 | 15 | 150 | 2 | IPR001606 | |
| Domain | ARID | 6.28e-03 | 15 | 150 | 2 | PS51011 | |
| Domain | Dynein_heavy | 6.28e-03 | 15 | 150 | 2 | PF03028 | |
| Domain | ARID | 6.28e-03 | 15 | 150 | 2 | PF01388 | |
| Domain | Dynein_heavy_dom | 6.28e-03 | 15 | 150 | 2 | IPR004273 | |
| Domain | PROTEIN_KINASE_DOM | 6.56e-03 | 493 | 150 | 10 | PS50011 | |
| Domain | - | DNAH10 ERCC6L CHD7 FANCM DICER1 DNAH1 DDX11 TRANK1 CTPS2 MPP4 YLPM1 GNAS HYDIN | 7.19e-03 | 746 | 150 | 13 | 3.40.50.300 |
| Domain | PH | 7.27e-03 | 278 | 150 | 7 | SM00233 | |
| Domain | TPR-contain_dom | 7.29e-03 | 150 | 150 | 5 | IPR013026 | |
| Domain | PH_domain | 7.55e-03 | 280 | 150 | 7 | IPR001849 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 1.99e-05 | 22 | 106 | 4 | M39821 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ARID4B MAP7D3 MAP1B ARID4A CHAF1A PDAP1 MSL1 ZDBF2 PRPF6 CHD7 FANCM WDR43 SCAF4 BPTF BRCA2 CTCF CBX5 YLPM1 SUPT16H HTATSF1 CDC5L MBD4 PRRC2A THRAP3 XRCC6 CUX1 TOP2B PCM1 | 1.70e-15 | 954 | 153 | 28 | 36373674 |
| Pubmed | SLC12A6 FLG MYLK RGPD8 MAP1B MYH7B SYNE1 CHAF1A PDAP1 PSMD2 MSL1 PRPF6 CNPY2 RYR2 DDX11 ACSL4 BPTF FRA10AC1 TNRC18 MLIP DST SLC12A4 CBX5 SYNE2 YLPM1 SUPT16H KIF5C RIMS2 THRAP3 XRCC6 CUX1 TOP2B RGPD5 | 4.74e-15 | 1442 | 153 | 33 | 35575683 | |
| Pubmed | TNIK CASC3 DMXL2 FMR1 RGPD8 NRCAM SYNE1 MINK1 NCAM1 DAPK3 CHD7 PTK2 STRIP1 DST CTCF SYNE2 YLPM1 SUPT16H KIF5C HERC2 CDC5L MAP4K4 PRRC2A THRAP3 XRCC6 CUX1 PCM1 | 1.73e-14 | 963 | 153 | 27 | 28671696 | |
| Pubmed | DMXL2 NRCAM MAP1B TEX2 HIPK1 DOCK9 MINK1 PSMD2 NCAM1 BCAN PTK2 STRIP1 DST MICAL3 RIMS2 PRRC2A PCM1 | 2.94e-13 | 347 | 153 | 17 | 17114649 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B ERCC6L ARID4A CHAF1A MINK1 PDAP1 CHD7 USP16 REXO1 PRDM2 STRIP1 SCAF4 BPTF MAP4K1 YLPM1 ZRANB2 MICAL3 MAP4K4 PRRC2A THRAP3 XRCC6 TOP2B PCM1 | 5.61e-13 | 774 | 153 | 23 | 15302935 |
| Pubmed | TNIK DMXL2 FRAS1 VEZT TEX2 SYNE1 MINK1 PRPF6 EXT2 CNPY2 APP USP16 DICER1 PLEKHG1 CBX5 SYNE2 SUPT16H ZRANB2 HTATSF1 PDZD8 GNAS HERC2 CDC5L SMCR8 MAP4K4 XRCC6 CUX1 TOP2B PCM1 | 1.37e-11 | 1487 | 153 | 29 | 33957083 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD8 ERCC6L SYNE1 DYNC2I1 MSL1 PRPF6 WDR43 STRIP1 CEP350 CEP120 CTCF YLPM1 GPATCH11 HTATSF1 MICAL3 GNAS MORC3 HERC2 CDC5L NEXN THRAP3 XRCC6 TOP2B PCM1 RGPD5 | 4.84e-11 | 1155 | 153 | 25 | 20360068 |
| Pubmed | DMXL2 NRCAM HIPK1 SYNE1 DYNC2I1 PSMD2 DNAAF9 APP USP16 GFPT1 PTK2 CEP350 DST NEMF YLPM1 PDZD8 KIF5C MORC3 LRBA HERC2 MBD4 MAP4K4 PRRC2A XRCC6 CUX1 PCM1 | 8.20e-11 | 1285 | 153 | 26 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MAP1B SYNE1 PSMD2 PRPF6 APP DICER1 WDR43 SCAF4 CEP350 BPTF DST CBX5 SYNE2 YLPM1 SUPT16H GNAS HERC2 CDC5L MAP4K4 THRAP3 XRCC6 TOP2B PCM1 | 1.53e-10 | 1024 | 153 | 23 | 24711643 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ARID4B ARID4A CHAF1A MSL1 CHD7 PRDM2 WDR43 FSIP2 BPTF CBX5 SUPT16H GPATCH11 MORC3 HERC2 MBD4 XRCC6 CUX1 TOP2B | 2.37e-10 | 608 | 153 | 18 | 36089195 |
| Pubmed | FMR1 CHAF1A PLCD4 CHD7 USP16 WDR43 BPTF CBX5 SUPT16H ZRANB2 GPATCH11 HTATSF1 MORC3 CDC5L HYDIN TOP2B | 3.28e-10 | 469 | 153 | 16 | 27634302 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CASC3 FMR1 RGPD8 MAP7D3 VEZT TEX2 SYNE1 PSMA1 DYNC2I1 PSMD2 DAPK3 DGKH ZDBF2 WDR43 STRIP1 ACSL4 DST UPF2 CBX5 SYNE2 SUPT16H PDZD8 GNAS HERC2 SMCR8 XRCC6 CUX1 | 4.24e-10 | 1496 | 153 | 27 | 32877691 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | FMR1 ARID4B MAP7D3 ARID4A CHAF1A MSL1 PRPF6 CHD7 FANCM PRDM2 WDR43 SCAF4 BPTF DST CTCF CBX5 YLPM1 SUPT16H HTATSF1 CDC5L MBD4 THRAP3 XRCC6 CUX1 TOP2B | 5.14e-10 | 1294 | 153 | 25 | 30804502 |
| Pubmed | TNIK CASC3 RGPD8 ERCC6L VEZT TEX2 CHAF1A DYNC2I1 ZDBF2 CHD7 DICER1 STRIP1 CEP350 YLPM1 GPATCH11 PDZD8 CDC5L MAP4K4 PCM1 | 6.68e-10 | 733 | 153 | 19 | 34672954 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SATB2 FMR1 NRCAM MAP1B PSMA1 CHD7 APP SYNE2 YLPM1 SUPT16H CDC5L RIMS2 THRAP3 TOP2B | 7.67e-10 | 358 | 153 | 14 | 32460013 |
| Pubmed | TNIK CASC3 FMR1 COBLL1 MSL1 PRPF6 CHD7 DICER1 GFPT1 WDR43 SCAF4 CEP350 ACSL4 UPF2 CTCF NEMF YLPM1 SUPT16H GPATCH11 GNAS HERC2 PRRC2A THRAP3 XRCC6 PCM1 | 1.67e-09 | 1371 | 153 | 25 | 36244648 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 CASC3 MAP1B VEZT FAM53A PSMA1 B3GALNT2 MINK1 DYNC2I1 DGKH APP PTK2 LRCH3 DNAH1 BPTF TNRC18 NEMF KATNIP MICAL3 KIF5C SPIDR GNAS LRBA THRAP3 CUX1 PCM1 | 1.87e-09 | 1489 | 153 | 26 | 28611215 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG DMXL2 MAP1B SYNE1 PDAP1 PRPF6 CHD7 SCAF4 BPTF DST UPF2 CBX5 NEMF YLPM1 SUPT16H ZRANB2 IRAK4 CDC5L MAP4K4 THRAP3 XRCC6 TOP2B | 2.49e-09 | 1082 | 153 | 22 | 38697112 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.36e-09 | 120 | 153 | 9 | 31413325 | |
| Pubmed | FLG SATB2 ARID4B DNAH10 ARID4A PSMA1 B3GALNT2 PSMD2 MSL1 CHD7 PRDM2 SCAF4 BPTF DST ZFHX4 CTCF SYNE2 YLPM1 HERC2 PRRC2A XRCC6 CUX1 PCM1 FILIP1L TANGO6 | 3.84e-09 | 1429 | 153 | 25 | 35140242 | |
| Pubmed | ARID4B MAP7D3 MAP1B ARID4A CHAF1A PDAP1 MSL1 CEP350 DST CBX5 SUPT16H MICAL3 MORC3 LRBA THRAP3 XRCC6 PCM1 | 4.40e-09 | 645 | 153 | 17 | 25281560 | |
| Pubmed | FMR1 MAP1B PSMD2 PRPF6 CHD7 DICER1 GFPT1 WDR43 BPTF DST CTCF SYNE2 YLPM1 HERC2 PRRC2A XRCC6 PCM1 | 5.28e-09 | 653 | 153 | 17 | 22586326 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | PDAP1 CHD7 WDR43 RTF1 BPTF YLPM1 SUPT16H ZRANB2 GPATCH11 THRAP3 XRCC6 TOP2B | 5.32e-09 | 283 | 153 | 12 | 30585729 |
| Pubmed | TNIK DMXL2 SYNE1 DOCK9 CHD7 DICER1 RTF1 CEP68 DST SYNE2 CDC5L | 5.43e-09 | 225 | 153 | 11 | 12168954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK MAP7D3 MAP1B ERCC6L PDAP1 USP16 GFPT1 WDR43 SCAF4 DST CTCF YLPM1 HTATSF1 LRBA CDC5L SMCR8 PRRC2A XRCC6 TOP2B PCM1 | 5.98e-09 | 934 | 153 | 20 | 33916271 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 7.94e-09 | 92 | 153 | 8 | 15840729 | |
| Pubmed | FMR1 RGPD8 SYNE1 COBLL1 MINK1 DST SUPT16H LRBA CDC5L THRAP3 TOP2B | 8.15e-09 | 234 | 153 | 11 | 36243803 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CASC3 MAP7D3 MAP1B ERCC6L TEX2 COBLL1 MINK1 DAPK3 CEP350 FSIP2 PLEKHG1 DST MAP4K1 SYNE2 KIF5C GNAS MORC3 MAP4K4 PCM1 | 9.16e-09 | 861 | 153 | 19 | 36931259 |
| Pubmed | MAP7D3 MAP1B ERCC6L PDAP1 SCAF4 BPTF YLPM1 LRBA CDC5L MAP4K4 PRRC2A THRAP3 CUX1 PCM1 RGPD5 | 2.34e-08 | 549 | 153 | 15 | 38280479 | |
| Pubmed | SATB2 FMR1 ARID4B MAP7D3 ERCC6L ZDBF2 CHD7 GFPT1 RYR2 CEP350 ACSL4 SYNE2 APOL6 GPATCH11 SMCR8 CUX1 | 2.56e-08 | 638 | 153 | 16 | 31182584 | |
| Pubmed | DMXL2 COBLL1 ANKRD62 FANCM REXO1 SCAF4 CEP350 CEP68 TNRC18 MICAL3 SPIDR MORC3 CDC5L TANGO6 | 4.38e-08 | 493 | 153 | 14 | 15368895 | |
| Pubmed | SLC12A6 DMXL2 FMR1 NRCAM MAP1B SYNE1 MINK1 PSMD2 NCAM1 DAPK3 BCAN PLEKHG5 STRIP1 LRCH3 MLIP DST UPF2 MICAL3 KIF5C CDC5L PRRC2A THRAP3 PCM1 | 8.07e-08 | 1431 | 153 | 23 | 37142655 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17611414 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 21854770 | ||
| Pubmed | MAP7D3 MAP1B ERCC6L COBLL1 MINK1 PDAP1 PSMD2 GFPT1 DST PDZD8 MICAL3 LRBA SMCR8 MAP4K4 PRRC2A XRCC6 | 1.06e-07 | 708 | 153 | 16 | 39231216 | |
| Pubmed | TNIK DMXL2 FMR1 RGPD8 NRCAM MAP1B VEZT TEX2 DOCK9 MINK1 PDAP1 PSMD2 NCAM1 ZDBF2 APP RYR2 TNRC18 MAP4K4 THRAP3 PCM1 | 1.53e-07 | 1139 | 153 | 20 | 36417873 | |
| Pubmed | 1.90e-07 | 191 | 153 | 9 | 31177093 | ||
| Pubmed | FMR1 DAPK3 PRPF6 WDR43 DST CBX5 YLPM1 SUPT16H KIF5C GNAS CDC5L THRAP3 XRCC6 TOP2B PCM1 | 2.53e-07 | 660 | 153 | 15 | 32780723 | |
| Pubmed | FMR1 RGPD8 SYNE1 PDAP1 WDR43 CTCF CBX5 NEMF SUPT16H PRRC2A TOP2B | 2.84e-07 | 332 | 153 | 11 | 25693804 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 25851535 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SATB2 ARID4B ARID4A ZDBF2 PRPF6 CHD7 ZFHX4 CTCF CBX5 SUPT16H CDC5L THRAP3 XRCC6 CUX1 | 3.36e-07 | 583 | 153 | 14 | 29844126 |
| Pubmed | SLC12A6 DMXL2 FMR1 SYNE1 DOCK9 LAMA2 LAMA4 DST UPF2 CBX5 SYNE2 SUPT16H XRCC6 | 3.45e-07 | 497 | 153 | 13 | 23414517 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.62e-07 | 150 | 153 | 8 | 28242625 | |
| Pubmed | SATB2 RGPD8 ZDBF2 CHD7 PRDM2 DST ZFHX4 BRCA2 LRBA CUX1 PCM1 TANGO6 | 3.73e-07 | 418 | 153 | 12 | 34709266 | |
| Pubmed | 4.06e-07 | 209 | 153 | 9 | 36779422 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | FLG SATB2 FMR1 PRPF6 ZFHX4 CBX5 YLPM1 SUPT16H HTATSF1 CDC5L THRAP3 XRCC6 CUX1 TOP2B | 5.23e-07 | 605 | 153 | 14 | 28977666 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.25e-07 | 281 | 153 | 10 | 28706196 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | TNIK SLC12A6 MAP1B MINK1 PSMD2 NCAM1 BCAN PTK2 DST BRCA2 ZRANB2 KIF5C GNAS MAP4K4 | 7.12e-07 | 621 | 153 | 14 | 22794259 |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9271224 | ||
| Pubmed | FMR1 MAP7D3 ERCC6L DOCK9 PSMD2 NCAM1 PRPF6 EXT2 CEP350 ACSL4 MAP4K1 PDZD8 GNAS LRBA HERC2 CDC5L PRRC2A XRCC6 PCM1 | 1.01e-06 | 1168 | 153 | 19 | 19946888 | |
| Pubmed | DMXL2 FRAS1 FMR1 MAP1B ERCC6L MINK1 DICER1 PTK2 DST UPF2 NEMF MICAL3 MAP4K4 DDX11L8 | 1.22e-06 | 650 | 153 | 14 | 38777146 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TNIK MAP7D3 PDAP1 DYNC2I1 GFPT1 CEP350 PLEKHG1 CEP120 BRCA2 CAPN7 MICAL3 KIF5C MORC3 HERC2 MAP4K4 PCM1 | 1.25e-06 | 853 | 153 | 16 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SATB2 ARID4B MAP7D3 MAP1B ARID4A HIPK1 CHAF1A ACSL4 BPTF SEPSECS ZFHX4 RTCA SPIDR THRAP3 CUX1 TOP2B | 1.33e-06 | 857 | 153 | 16 | 25609649 |
| Pubmed | FMR1 MSL1 PRPF6 DICER1 GFPT1 TNRC18 CTCF YLPM1 ZRANB2 GNAS CDC5L PRRC2A THRAP3 XRCC6 | 1.33e-06 | 655 | 153 | 14 | 35819319 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | FMR1 ARID4B MAP7D3 MAP1B PRPF6 WDR43 BPTF UPF2 NEMF SUPT16H HERC2 CDC5L PRRC2A XRCC6 TOP2B | 1.45e-06 | 759 | 153 | 15 | 35915203 |
| Pubmed | 1.63e-06 | 183 | 153 | 8 | 36129980 | ||
| Pubmed | ARAP, a Novel Adaptor Protein, Is Required for TCR Signaling and Integrin-Mediated Adhesion. | 1.65e-06 | 6 | 153 | 3 | 27335501 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SATB2 ERCC6L CHD7 APP PRDM2 TNRC18 ZFHX4 SYNE2 SMCR8 CUX1 TANGO6 | 1.68e-06 | 398 | 153 | 11 | 35016035 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.75e-06 | 321 | 153 | 10 | 32098917 | |
| Pubmed | ARID4B HIPK1 SYNE1 CHAF1A COBLL1 LAMA4 PTK2 CEP350 DST HERC2 MAP4K4 CUX1 | 1.80e-06 | 486 | 153 | 12 | 20936779 | |
| Pubmed | 1.86e-06 | 251 | 153 | 9 | 31076518 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B PSMA1 PSMD2 PRPF6 CHD7 USP16 GFPT1 PTK2 ACSL4 DST UPF2 RTCA SUPT16H RIC8A HERC2 CDC5L NEXN THRAP3 XRCC6 TOP2B | 2.22e-06 | 1353 | 153 | 20 | 29467282 |
| Pubmed | PSMA1 CHAF1A PRPF6 GFPT1 RTF1 BPTF CTCF CBX5 RTCA YLPM1 SUPT16H HTATSF1 CDC5L MBD4 THRAP3 XRCC6 TOP2B | 2.61e-06 | 1014 | 153 | 17 | 32416067 | |
| Pubmed | SLC12A6 DMXL2 VEZT TEX2 LRCH3 ACSL4 DST SLC12A4 SYNE2 PDZD8 LRBA SMCR8 | 2.62e-06 | 504 | 153 | 12 | 34432599 | |
| Pubmed | SATB2 COBLL1 DAPK3 PRPF6 SCAF4 RTF1 DST YLPM1 ZRANB2 HTATSF1 CDC5L THRAP3 | 2.73e-06 | 506 | 153 | 12 | 30890647 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TNIK MAP1B PRPF6 GFPT1 CTPS2 UPF2 CBX5 RTCA SUPT16H HTATSF1 RIC8A KIF5C LRBA TOP2B | 3.07e-06 | 704 | 153 | 14 | 29955894 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FMR1 MAP7D3 MAP1B MINK1 PDAP1 USP16 DICER1 PTK2 CEP350 UPF2 YLPM1 PRRC2A THRAP3 TOP2B | 4.24e-06 | 724 | 153 | 14 | 36232890 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FMR1 RGPD8 MAP1B PSMD2 PRPF6 CHD7 SUPT16H HERC2 THRAP3 XRCC6 CUX1 PCM1 RGPD5 | 4.41e-06 | 626 | 153 | 13 | 33644029 |
| Pubmed | 4.50e-06 | 55 | 153 | 5 | 18570454 | ||
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 22678773 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FMR1 DNAH10 SYNE1 PSMA1 CHAF1A PSMD2 PRPF6 DICER1 GFPT1 PRDM2 WDR43 NEMF SUPT16H ZRANB2 GNAS CDC5L MAP4K4 THRAP3 XRCC6 TOP2B | 4.82e-06 | 1425 | 153 | 20 | 30948266 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 5.32e-06 | 364 | 153 | 10 | 24778252 | |
| Pubmed | MAP1B PSMA1 PDAP1 PSMD2 PRPF6 DICER1 LRCH3 DST SYNE2 SUPT16H MICAL3 GNAS CDC5L NEXN PRRC2A THRAP3 XRCC6 CUX1 TOP2B PCM1 | 5.62e-06 | 1440 | 153 | 20 | 30833792 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.36e-06 | 220 | 153 | 8 | 35785414 | |
| Pubmed | ARID4B ARID4A CHAF1A PSMD2 MSL1 ZDBF2 USP16 DICER1 GFPT1 WDR43 FBXL5 RTF1 SLC12A4 UPF2 YLPM1 SUPT16H RIC8A MAP4K4 PCM1 | 6.40e-06 | 1327 | 153 | 19 | 32694731 | |
| Pubmed | SATB2 PSMA1 ZNF652 PDAP1 PRPF6 CHD7 PRDM2 SCAF4 BPTF TNRC18 ZRANB2 PRRC2A THRAP3 XRCC6 CUX1 TOP2B PCM1 | 7.91e-06 | 1103 | 153 | 17 | 34189442 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PSMA1 CHAF1A PSMD2 PRPF6 WDR43 RTF1 BPTF CTCF YLPM1 SUPT16H ZRANB2 PDZD8 CDC5L THRAP3 XRCC6 TOP2B | 8.18e-06 | 989 | 153 | 16 | 36424410 |
| Pubmed | ARID4A VEZT TEX2 PDAP1 ZDBF2 DST SLC12A4 SYNE2 PDZD8 LRBA CUX1 PCM1 | 8.79e-06 | 568 | 153 | 12 | 37774976 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLG CASC3 PSMD2 DST SUPT16H HTATSF1 NEXN THRAP3 XRCC6 CUX1 PCM1 | 9.36e-06 | 477 | 153 | 11 | 31300519 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLG MAP1B PSMD2 PRPF6 USP16 DICER1 STRIP1 CTPS2 RTCA YLPM1 SUPT16H ZRANB2 HERC2 MAP4K4 PRRC2A RGPD5 | 9.98e-06 | 1005 | 153 | 16 | 19615732 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.06e-05 | 394 | 153 | 10 | 27248496 | |
| Pubmed | Regulation of radial glial survival by signals from the meninges. | 1.34e-05 | 11 | 153 | 3 | 19535581 | |
| Pubmed | 1.34e-05 | 11 | 153 | 3 | 18406329 | ||
| Pubmed | 1.39e-05 | 322 | 153 | 9 | 26514267 | ||
| Pubmed | TNIK FRAS1 NRCAM HIPK1 SYNE1 DOCK9 STRIP1 PLEKHG1 KATNIP MICAL3 | 1.40e-05 | 407 | 153 | 10 | 12693553 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | FMR1 RGPD8 PSMA1 LRCH3 CBX5 RTCA YLPM1 SUPT16H ZRANB2 PRRC2A XRCC6 TOP2B PCM1 | 1.47e-05 | 701 | 153 | 13 | 30196744 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ERCC6L PSMA1 CHAF1A PSMD2 PRPF6 EXT2 PTK2 STRIP1 RTF1 RTCA ZRANB2 HTATSF1 KIF5C GNAS LRBA HERC2 CDC5L THRAP3 | 1.52e-05 | 1284 | 153 | 18 | 17353931 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | MAP7D3 PRPF6 CHD7 BPTF CEP120 YLPM1 MORC3 CDC5L THRAP3 XRCC6 | 1.52e-05 | 411 | 153 | 10 | 35182466 |
| Pubmed | FLG FMR1 PRPF6 GFPT1 LRCH3 CTCF NEMF SUPT16H RIC8A MAP4K4 THRAP3 TOP2B | 1.54e-05 | 601 | 153 | 12 | 33658012 | |
| Pubmed | 1.65e-05 | 251 | 153 | 8 | 29778605 | ||
| Pubmed | VEZT MINK1 PSMD2 DAPK3 APP CEP350 ACSL4 SLC12A4 SYNE2 YLPM1 SUPT16H PDZD8 MICAL3 HERC2 CDC5L PRRC2A | 1.69e-05 | 1049 | 153 | 16 | 27880917 | |
| Pubmed | Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | 1.70e-05 | 35 | 153 | 4 | 37758766 | |
| Pubmed | 1.78e-05 | 12 | 153 | 3 | 9396756 | ||
| Pubmed | 1.87e-05 | 421 | 153 | 10 | 36976175 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20180882 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21525391 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 1.92e-05 | 2 | 153 | 2 | 34031912 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11792814 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 18081712 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.92e-05 | 2 | 153 | 2 | 24931616 | |
| Interaction | SMC5 interactions | ARID4B MAP7D3 MAP1B ARID4A CHAF1A PDAP1 MSL1 ZDBF2 PRPF6 CHD7 FANCM WDR43 SCAF4 BPTF BRCA2 CTCF CBX5 YLPM1 SUPT16H HTATSF1 CDC5L MBD4 PRRC2A THRAP3 XRCC6 CUX1 TOP2B PCM1 | 1.88e-09 | 1000 | 153 | 28 | int:SMC5 |
| Interaction | H2BC9 interactions | FRAS1 DNAH10 MAP1B ERCC6L LAMA2 PDAP1 DNAH1 CEP350 FSIP2 ACSL4 BPTF TNRC18 DST ZFHX4 YLPM1 SUPT16H PRRC2A | 5.29e-08 | 446 | 153 | 17 | int:H2BC9 |
| Interaction | NUP43 interactions | ARID4B RGPD8 ARID4A PSMA1 MSL1 ZDBF2 PRPF6 RYR2 PRDM2 WDR43 RTF1 FSIP2 BPTF DST BRCA2 CTCF SYNE2 SUPT16H TOP2B RGPD5 | 5.91e-08 | 625 | 153 | 20 | int:NUP43 |
| Interaction | H2BC8 interactions | ARID4B ARID4A CHAF1A PDAP1 MSL1 CHD7 WDR43 RTF1 BPTF CTCF CBX5 SUPT16H ZRANB2 MORC3 TDP1 MBD4 XRCC6 CUX1 TOP2B | 8.13e-08 | 576 | 153 | 19 | int:H2BC8 |
| Interaction | H2BC4 interactions | FMR1 MAP1B PDAP1 USP16 DNAH1 CEP350 FSIP2 TNRC18 UPF2 MAP4K4 PRRC2A XRCC6 TOP2B | 9.36e-08 | 259 | 153 | 13 | int:H2BC4 |
| Interaction | KIF20A interactions | FMR1 RGPD8 SYNE1 MINK1 PRPF6 WDR43 AGBL3 LRCH3 ACSL4 PIEZO2 MLIP CBX5 SYNE2 YLPM1 SUPT16H ZRANB2 PDZD8 GNAS HERC2 MBD4 MAP4K4 PRRC2A THRAP3 XRCC6 TOP2B PCM1 | 9.54e-08 | 1052 | 153 | 26 | int:KIF20A |
| Interaction | OBSL1 interactions | SYNE1 PSMA1 PSMD2 PRPF6 APP WDR43 SCAF4 DNAH1 DST CBX5 SYNE2 NEMF YLPM1 SUPT16H ZRANB2 HERC2 CDC5L MAP4K4 THRAP3 XRCC6 TOP2B PCM1 | 1.30e-06 | 902 | 153 | 22 | int:OBSL1 |
| Interaction | TNIK interactions | TNIK FMR1 SYNE1 MINK1 STRIP1 DST SYNE2 SUPT16H KIF5C HERC2 CDC5L MAP4K4 THRAP3 PCM1 | 1.30e-06 | 381 | 153 | 14 | int:TNIK |
| Interaction | CCT8L2 interactions | 3.22e-06 | 157 | 153 | 9 | int:CCT8L2 | |
| Interaction | RBPJ interactions | SATB2 MAP7D3 CHAF1A CHD7 APP RTF1 SEPSECS CBX5 TDP1 XRCC6 CUX1 | 3.96e-06 | 254 | 153 | 11 | int:RBPJ |
| Interaction | H3C1 interactions | ARID4B SYNE1 CHAF1A COBLL1 LAMA2 MSL1 CHD7 PRDM2 DNAH1 BPTF TNRC18 PIEZO2 CTCF CBX5 SUPT16H ZRANB2 MORC3 THRAP3 XRCC6 CUX1 TOP2B | 4.71e-06 | 901 | 153 | 21 | int:H3C1 |
| Interaction | POLR1G interactions | ARID4B CHAF1A PRPF6 CHD7 PRDM2 WDR43 RTF1 BPTF CTCF CBX5 SKAP1 SUPT16H ZRANB2 XRCC6 TOP2B | 4.97e-06 | 489 | 153 | 15 | int:POLR1G |
| Interaction | H2AZ1 interactions | ARID4B MSL1 USP16 DNAH1 BPTF UPF2 CTCF CBX5 SUPT16H MAP4K4 THRAP3 XRCC6 TOP2B | 5.31e-06 | 371 | 153 | 13 | int:H2AZ1 |
| Interaction | H3C3 interactions | ARID4A CHAF1A MSL1 CHD7 PRDM2 WDR43 FSIP2 BPTF CBX5 SUPT16H MORC3 MBD4 XRCC6 CUX1 TOP2B | 5.75e-06 | 495 | 153 | 15 | int:H3C3 |
| Interaction | H2BC21 interactions | ARID4B MAP1B ARID4A CHAF1A MSL1 CHD7 PRDM2 SCAF4 RTF1 BPTF CBX5 MAP4K1 SUPT16H FYB1 MAP4K4 PRRC2A XRCC6 TOP2B | 5.87e-06 | 696 | 153 | 18 | int:H2BC21 |
| Interaction | IK interactions | ZDBF2 PRPF6 APP FRA10AC1 SUPT16H HTATSF1 CDC5L THRAP3 XRCC6 TOP2B | 5.90e-06 | 215 | 153 | 10 | int:IK |
| Interaction | PARP1 interactions | MORC1 SATB2 ARID4B PSMD2 MSL1 PRPF6 CHD7 PTK2 PRDM2 WDR43 RTF1 BPTF BRCA2 CTCF CBX5 SUPT16H ZRANB2 RIC8A MORC3 CDC5L TDP1 MAP4K4 THRAP3 XRCC6 CUX1 TOP2B | 6.39e-06 | 1316 | 153 | 26 | int:PARP1 |
| Interaction | HDLBP interactions | TNIK FMR1 PRPF6 CHD7 USP16 GFPT1 SCAF4 ACSL4 UPF2 CTCF CBX5 YLPM1 SUPT16H PDZD8 GNAS HERC2 CDC5L PRRC2A THRAP3 XRCC6 | 7.68e-06 | 855 | 153 | 20 | int:HDLBP |
| Interaction | ERG interactions | 8.13e-06 | 223 | 153 | 10 | int:ERG | |
| Interaction | ARID1A interactions | ARID4B CHAF1A MSL1 CHD7 RTF1 BPTF BRCA2 CTCF SUPT16H CDC5L TOP2B | 8.72e-06 | 276 | 153 | 11 | int:ARID1A |
| Interaction | MED4 interactions | MAP7D3 MAP1B PDAP1 SCAF4 CEP350 DST CEP120 SUPT16H MICAL3 LRBA HERC2 THRAP3 PCM1 RGPD5 | 8.89e-06 | 450 | 153 | 14 | int:MED4 |
| Interaction | DUXB interactions | 9.00e-06 | 18 | 153 | 4 | int:DUXB | |
| Interaction | KIF23 interactions | FLG FMR1 PSMA1 COBLL1 MINK1 LAMA2 ZNF200 PSMD2 PRPF6 GFPT1 WDR43 ACSL4 TNRC18 CTPS2 SUPT16H ZRANB2 MICAL3 GNAS MAP4K4 THRAP3 XRCC6 TOP2B | 1.11e-05 | 1031 | 153 | 22 | int:KIF23 |
| Interaction | GOLGA1 interactions | 1.12e-05 | 183 | 153 | 9 | int:GOLGA1 | |
| Interaction | SIRT7 interactions | FMR1 MAP1B PSMD2 PRPF6 CHD7 APP DICER1 GFPT1 WDR43 BPTF DST CTCF SYNE2 YLPM1 HERC2 PRRC2A XRCC6 PCM1 | 1.45e-05 | 744 | 153 | 18 | int:SIRT7 |
| Interaction | FMR1 interactions | TNIK CASC3 FMR1 MAP1B DAPK3 CHD7 SUPT16H KIF5C HERC2 CDC5L MAP4K4 PRRC2A THRAP3 CUX1 PCM1 | 1.48e-05 | 536 | 153 | 15 | int:FMR1 |
| Interaction | PCNT interactions | 1.60e-05 | 241 | 153 | 10 | int:PCNT | |
| Interaction | NAA40 interactions | TNIK MAP7D3 MAP1B ERCC6L PDAP1 USP16 GFPT1 WDR43 SCAF4 DST CTCF YLPM1 SUPT16H HTATSF1 LRBA CDC5L SMCR8 PRRC2A XRCC6 TOP2B PCM1 | 1.63e-05 | 978 | 153 | 21 | int:NAA40 |
| Interaction | EEF1AKMT2 interactions | 1.80e-05 | 43 | 153 | 5 | int:EEF1AKMT2 | |
| Interaction | BCL11B interactions | 2.10e-05 | 74 | 153 | 6 | int:BCL11B | |
| Interaction | ZRANB2 interactions | 2.18e-05 | 199 | 153 | 9 | int:ZRANB2 | |
| Interaction | VPS33B interactions | 2.18e-05 | 199 | 153 | 9 | int:VPS33B | |
| Interaction | ATG16L1 interactions | FMR1 ERCC6L PSMA1 COBLL1 PSMD2 APP RYR2 STRIP1 LRCH3 CEP350 PLEKHG1 SLC12A4 CBX5 RTCA YLPM1 SUPT16H ZRANB2 KATNIP PRRC2A XRCC6 TOP2B PCM1 RGPD5 | 2.25e-05 | 1161 | 153 | 23 | int:ATG16L1 |
| Interaction | YWHAG interactions | CASC3 MAP7D3 ERCC6L DOCK9 CHAF1A COBLL1 MINK1 DAPK3 APP PLEKHG5 PTK2 LRCH3 CEP350 PLEKHG1 DST SYNE2 KIF5C GNAS MORC3 LRBA CDC5L MAP4K4 THRAP3 PCM1 | 2.37e-05 | 1248 | 153 | 24 | int:YWHAG |
| Interaction | DISC1 interactions | TNIK RGPD8 SYNE1 PDAP1 CEP350 DST HERC2 CDC5L MAP4K4 NEXN XRCC6 PCM1 RGPD5 | 2.48e-05 | 429 | 153 | 13 | int:DISC1 |
| Interaction | KDM1A interactions | TNIK SATB2 FMR1 CHAF1A ZDBF2 CHD7 PRDM2 CEP350 SEPSECS DST ZFHX4 BRCA2 SUPT16H FAM9A LRBA CDC5L MBD4 CUX1 PCM1 TANGO6 | 3.06e-05 | 941 | 153 | 20 | int:KDM1A |
| Interaction | MAGEA9 interactions | 3.09e-05 | 208 | 153 | 9 | int:MAGEA9 | |
| Interaction | IFI16 interactions | FMR1 RGPD8 MAP1B SYNE1 PDAP1 PSMD2 APP WDR43 LRCH3 CTCF CBX5 NEMF SUPT16H CDC5L PRRC2A XRCC6 TOP2B | 3.12e-05 | 714 | 153 | 17 | int:IFI16 |
| Interaction | SOX5 interactions | 3.38e-05 | 162 | 153 | 8 | int:SOX5 | |
| Interaction | H2BC12 interactions | MAP1B PDAP1 USP16 CEP350 TNRC18 DST UPF2 CBX5 YLPM1 PRRC2A TOP2B | 3.63e-05 | 322 | 153 | 11 | int:H2BC12 |
| Interaction | ZNF330 interactions | ARID4B CHAF1A MSL1 PRPF6 CHD7 WDR43 RTF1 CBX5 SUPT16H ZRANB2 XRCC6 CUX1 TOP2B | 3.71e-05 | 446 | 153 | 13 | int:ZNF330 |
| Interaction | MAPRE1 interactions | CASC3 FMR1 MAP7D3 MAP1B VEZT PSMA1 APP CEP350 DST HERC2 NEXN PRRC2A PCM1 RGPD5 | 3.87e-05 | 514 | 153 | 14 | int:MAPRE1 |
| Interaction | MKRN2 interactions | SATB2 FMR1 NRCAM MAP1B CHD7 APP SYNE2 CDC5L RIMS2 PRRC2A THRAP3 TOP2B | 3.92e-05 | 385 | 153 | 12 | int:MKRN2 |
| Interaction | CCDC92 interactions | 5.05e-05 | 53 | 153 | 5 | int:CCDC92 | |
| Interaction | USP7 interactions | FMR1 TRPA1 RGPD8 ERCC6L VEZT SYNE1 COBLL1 MINK1 PSMD2 ZDBF2 APP PLEKHG5 DICER1 AGBL3 DST YLPM1 SUPT16H MMRN2 LRBA CDC5L MBD4 THRAP3 TOP2B TTLL13 | 5.33e-05 | 1313 | 153 | 24 | int:USP7 |
| Interaction | GSK3A interactions | TNIK FMR1 MAP7D3 TEX2 ZDBF2 APP DICER1 CEP350 TNRC18 DST MICAL3 THRAP3 PCM1 | 5.56e-05 | 464 | 153 | 13 | int:GSK3A |
| Interaction | H3-3A interactions | ARID4B CHAF1A DYNC2I1 MSL1 CHD7 PRDM2 BPTF CBX5 SUPT16H GPATCH11 MORC3 HERC2 MBD4 THRAP3 XRCC6 CUX1 TOP2B | 5.65e-05 | 749 | 153 | 17 | int:H3-3A |
| Interaction | BIN1 interactions | 5.84e-05 | 129 | 153 | 7 | int:BIN1 | |
| Interaction | DNAJC25 interactions | 6.44e-05 | 284 | 153 | 10 | int:DNAJC25 | |
| Interaction | NUPR1 interactions | FMR1 DAPK3 MSL1 PRPF6 WDR43 DST CBX5 YLPM1 SUPT16H KIF5C GNAS CDC5L THRAP3 XRCC6 TOP2B PCM1 | 6.54e-05 | 683 | 153 | 16 | int:NUPR1 |
| Interaction | SH3BP5 interactions | 7.51e-05 | 30 | 153 | 4 | int:SH3BP5 | |
| Interaction | CUL7 interactions | MAP1B PSMD2 PRPF6 APP GFPT1 WDR43 BPTF CBX5 MAP4K1 SYNE2 SUPT16H ZRANB2 CDC5L NEXN PRRC2A THRAP3 XRCC6 TOP2B | 7.63e-05 | 845 | 153 | 18 | int:CUL7 |
| Interaction | MTNR1B interactions | 7.79e-05 | 135 | 153 | 7 | int:MTNR1B | |
| Interaction | ACTC1 interactions | SATB2 MYLK SYNE1 COBLL1 DAPK3 PRPF6 SCAF4 RTF1 DST SYNE2 YLPM1 ZRANB2 HTATSF1 CDC5L NEXN THRAP3 | 7.88e-05 | 694 | 153 | 16 | int:ACTC1 |
| Interaction | FGFR1OP2 interactions | 8.15e-05 | 94 | 153 | 6 | int:FGFR1OP2 | |
| Interaction | FILIP1 interactions | 8.57e-05 | 31 | 153 | 4 | int:FILIP1 | |
| Interaction | MYCBP2 interactions | TNIK FMR1 RGPD8 TRANK1 DST SKAP1 SYNE2 HERC2 MAP4K4 THRAP3 PCM1 | 8.73e-05 | 355 | 153 | 11 | int:MYCBP2 |
| Interaction | SIRT6 interactions | FMR1 RGPD8 DYNC2I1 PSMD2 ZDBF2 PRPF6 DICER1 GFPT1 LRCH3 YLPM1 SUPT16H HERC2 XRCC6 TOP2B RGPD5 | 9.01e-05 | 628 | 153 | 15 | int:SIRT6 |
| Interaction | APEX1 interactions | ARID4B ARID4A DOCK9 CHAF1A DAPK3 CHD7 APP PLEKHG5 PRDM2 WDR43 RTF1 BPTF SLC12A4 BRCA2 RIC8A SPIDR PRRC2A THRAP3 XRCC6 CUX1 TOP2B PCM1 FILIP1L | 9.04e-05 | 1271 | 153 | 23 | int:APEX1 |
| Interaction | YWHAH interactions | CASC3 MAP7D3 ERCC6L TEX2 DOCK9 COBLL1 MINK1 PSMD2 DAPK3 PRPF6 PLEKHG5 CEP350 PLEKHG1 DST SYNE2 KIF5C MORC3 LRBA RIMS2 MAP4K4 PCM1 | 9.20e-05 | 1102 | 153 | 21 | int:YWHAH |
| Interaction | HNF1B interactions | 1.04e-04 | 190 | 153 | 8 | int:HNF1B | |
| Interaction | RCOR1 interactions | TNIK SATB2 ARID4A ZDBF2 CHD7 SEPSECS DST ZFHX4 BRCA2 LRBA CUX1 PCM1 TANGO6 | 1.04e-04 | 494 | 153 | 13 | int:RCOR1 |
| Interaction | HTT interactions | TNIK SLC12A6 MAP1B ERCC6L PSMA1 MINK1 PSMD2 NCAM1 BCAN PTK2 DST BRCA2 ZRANB2 KIF5C GNAS MORC3 MBD4 MAP4K4 XRCC6 | 1.08e-04 | 949 | 153 | 19 | int:HTT |
| Interaction | RPL13AP3 interactions | 1.10e-04 | 33 | 153 | 4 | int:RPL13AP3 | |
| Interaction | KCNA3 interactions | MAP7D3 MAP1B ERCC6L MYH7B COBLL1 MINK1 PDAP1 PSMD2 GFPT1 PRDM2 DST PDZD8 MICAL3 LRBA SMCR8 MAP4K4 PRRC2A XRCC6 | 1.12e-04 | 871 | 153 | 18 | int:KCNA3 |
| Interaction | ZBTB7B interactions | SYNE1 ZFHX4 CBX5 SUPT16H GNAS TDP1 PRRC2A THRAP3 XRCC6 CUX1 TOP2B | 1.14e-04 | 366 | 153 | 11 | int:ZBTB7B |
| Interaction | ETAA1 interactions | 1.22e-04 | 145 | 153 | 7 | int:ETAA1 | |
| Interaction | CBX3 interactions | FMR1 CHAF1A COBLL1 MSL1 CHD7 WDR43 RTF1 CBX5 SUPT16H ZRANB2 HTATSF1 MAP4K4 XRCC6 CUX1 TOP2B | 1.23e-04 | 646 | 153 | 15 | int:CBX3 |
| Interaction | RAB35 interactions | SLC12A6 VEZT TEX2 DOCK9 MINK1 NCAM1 APP DST SLC12A4 SYNE2 PDZD8 MICAL3 SMCR8 MAP4K4 | 1.23e-04 | 573 | 153 | 14 | int:RAB35 |
| Interaction | HERC2 interactions | TNIK FMR1 PSMD2 USP16 FBXL5 DST SYNE2 RIC8A KIF5C GNAS HERC2 CUX1 PCM1 | 1.25e-04 | 503 | 153 | 13 | int:HERC2 |
| Interaction | KCTD13 interactions | SLC12A6 DMXL2 FMR1 NRCAM MAP1B SYNE1 PSMA1 MINK1 PSMD2 NCAM1 DAPK3 BCAN PLEKHG5 STRIP1 LRCH3 MLIP DST UPF2 MICAL3 KIF5C CDC5L PRRC2A THRAP3 PCM1 | 1.35e-04 | 1394 | 153 | 24 | int:KCTD13 |
| Interaction | RBBP7 interactions | ARID4B MAP1B ARID4A PSMA1 CHAF1A PSMD2 BPTF TNRC18 BRCA2 CTCF CBX5 CDC5L THRAP3 | 1.35e-04 | 507 | 153 | 13 | int:RBBP7 |
| Interaction | H2AC18 interactions | 1.39e-04 | 148 | 153 | 7 | int:H2AC18 | |
| Interaction | PLK1 interactions | SATB2 MAP1B ERCC6L PSMA1 DYNC2I1 APP USP16 DICER1 PTK2 FBXL5 BRCA2 CDC5L PCM1 | 1.43e-04 | 510 | 153 | 13 | int:PLK1 |
| Interaction | NIPBL interactions | 1.43e-04 | 199 | 153 | 8 | int:NIPBL | |
| Interaction | CENPA interactions | CHAF1A PRPF6 CHD7 PRDM2 RTF1 BPTF CBX5 SUPT16H XRCC6 CUX1 TOP2B | 1.48e-04 | 377 | 153 | 11 | int:CENPA |
| Interaction | THRAP3 interactions | TNIK CASC3 FMR1 MAP1B PRPF6 UPF2 BRCA2 CTCF MAP4K1 PDZD8 THRAP3 XRCC6 | 1.48e-04 | 443 | 153 | 12 | int:THRAP3 |
| Interaction | AP3M1 interactions | 1.51e-04 | 150 | 153 | 7 | int:AP3M1 | |
| Interaction | CENPS interactions | 1.56e-04 | 36 | 153 | 4 | int:CENPS | |
| Interaction | UCHL5 interactions | 1.67e-04 | 319 | 153 | 10 | int:UCHL5 | |
| Interaction | STRIP2 interactions | 1.68e-04 | 68 | 153 | 5 | int:STRIP2 | |
| Interaction | ING2 interactions | 1.68e-04 | 68 | 153 | 5 | int:ING2 | |
| Interaction | NCK2 interactions | 1.81e-04 | 262 | 153 | 9 | int:NCK2 | |
| Interaction | BARD1 interactions | ERCC6L SCAF4 BRCA2 CBX5 PDZD8 MICAL3 HERC2 THRAP3 XRCC6 TOP2B | 1.85e-04 | 323 | 153 | 10 | int:BARD1 |
| Interaction | AGBL4 interactions | 1.92e-04 | 70 | 153 | 5 | int:AGBL4 | |
| Interaction | TNR interactions | 1.93e-04 | 38 | 153 | 4 | int:TNR | |
| Interaction | WRN interactions | 1.94e-04 | 110 | 153 | 6 | int:WRN | |
| Interaction | AGAP2 interactions | 2.07e-04 | 210 | 153 | 8 | int:AGAP2 | |
| Interaction | SMARCA4 interactions | FMR1 ARID4B CHAF1A CHD7 BPTF UPF2 CTCF CBX5 SUPT16H CDC5L XRCC6 TOP2B | 2.18e-04 | 462 | 153 | 12 | int:SMARCA4 |
| Interaction | SSRP1 interactions | SATB2 CHAF1A PRPF6 REXO1 SCAF4 RTF1 BRCA2 YLPM1 SUPT16H MORC3 TDP1 PRRC2A THRAP3 XRCC6 TOP2B | 2.32e-04 | 685 | 153 | 15 | int:SSRP1 |
| Interaction | STRN4 interactions | 2.42e-04 | 162 | 153 | 7 | int:STRN4 | |
| Interaction | CFAP184 interactions | 2.42e-04 | 162 | 153 | 7 | int:CFAP184 | |
| Interaction | XRCC6 interactions | MAP1B CHAF1A PDAP1 CHD7 WDR43 RTF1 BPTF TNRC18 BRCA2 CBX5 YLPM1 SUPT16H ZRANB2 GPATCH11 PDZD8 THRAP3 XRCC6 TOP2B | 2.44e-04 | 928 | 153 | 18 | int:XRCC6 |
| Interaction | TRIR interactions | 2.50e-04 | 74 | 153 | 5 | int:TRIR | |
| Interaction | NEURL4 interactions | 2.59e-04 | 116 | 153 | 6 | int:NEURL4 | |
| Interaction | GUSBP5 interactions | 2.66e-04 | 75 | 153 | 5 | int:GUSBP5 | |
| Interaction | HDAC1 interactions | SATB2 ARID4B ARID4A CHAF1A PSMD2 ZDBF2 LRCH3 BPTF TNRC18 DST ZFHX4 BRCA2 CTCF SYNE2 LRBA MBD4 CUX1 TOP2B PCM1 TANGO6 | 2.80e-04 | 1108 | 153 | 20 | int:HDAC1 |
| Interaction | MECP2 interactions | FLG DMXL2 MAP1B SYNE1 PDAP1 PRPF6 CHD7 SCAF4 BPTF DST UPF2 CBX5 NEMF YLPM1 SUPT16H ZRANB2 IRAK4 CDC5L MAP4K4 THRAP3 XRCC6 TOP2B | 2.91e-04 | 1287 | 153 | 22 | int:MECP2 |
| Interaction | INSYN1 interactions | 3.13e-04 | 169 | 153 | 7 | int:INSYN1 | |
| Interaction | EZR interactions | TNIK MYLK COBLL1 MINK1 PDAP1 ZSWIM2 PTK2 DST NEMF PDZD8 RIC8A KIF5C LRBA | 3.14e-04 | 553 | 153 | 13 | int:EZR |
| Cytoband | 3p24 | 3.05e-04 | 8 | 153 | 2 | 3p24 | |
| Cytoband | 15q13 | 3.91e-04 | 9 | 153 | 2 | 15q13 | |
| GeneFamily | DNA helicases | 1.06e-04 | 17 | 100 | 3 | 1167 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.80e-04 | 4 | 100 | 2 | 1252 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 3.00e-04 | 5 | 100 | 2 | 655 | |
| GeneFamily | Zinc fingers CW-type | 6.25e-04 | 7 | 100 | 2 | 96 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.06e-03 | 9 | 100 | 2 | 527 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.61e-03 | 11 | 100 | 2 | 1168 | |
| GeneFamily | Laminin subunits | 1.93e-03 | 12 | 100 | 2 | 626 | |
| GeneFamily | AT-rich interaction domain containing | 3.03e-03 | 15 | 100 | 2 | 418 | |
| GeneFamily | Dyneins, axonemal | 3.90e-03 | 17 | 100 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.37e-03 | 18 | 100 | 2 | 91 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.39e-03 | 20 | 100 | 2 | 548 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 5.39e-03 | 20 | 100 | 2 | 1371 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.74e-03 | 206 | 100 | 5 | 682 | |
| GeneFamily | F-box and leucine rich repeat proteins | 5.94e-03 | 21 | 100 | 2 | 558 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 SATB2 MAP1B ARID4A DOCK9 APP DICER1 PTK2 WDR43 CEP350 ACSL4 BPTF DST UPF2 BRCA2 CTCF SYNE2 MICAL3 KIF5C SPIDR CUX1 FILIP1L | 5.76e-09 | 856 | 153 | 22 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FMR1 ARID4B MAP7D3 ARID4A HIPK1 SYNE1 ZNF652 DOCK9 DICER1 PRDM2 CEP350 ACSL4 BPTF TRANK1 CTCF MAP4K1 SKAP1 NEMF IRAK4 GNAS LRBA FYB1 THRAP3 XRCC6 TOP2B PCM1 | 5.25e-07 | 1492 | 153 | 26 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD8 HIPK1 DOCK9 PDAP1 PTK2 SCAF4 DNAH1 CEP68 CBX5 GNAS CDC5L MBD4 SMCR8 RGPD5 | 8.02e-07 | 474 | 153 | 14 | M40991 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.00e-06 | 90 | 153 | 7 | M39250 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | DDX12P NRCAM CHAF1A NCAM1 CHD7 FANCM DDX11 BRCA2 CBX5 SUPT16H KIF5C MBD4 RIMS2 DDX11L8 XRCC6 PCM1 | 2.51e-06 | 680 | 153 | 16 | MM456 |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 2.61e-06 | 198 | 153 | 9 | M7610 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 2.83e-06 | 200 | 153 | 9 | M3251 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | SATB2 ERCC6L ZNF652 COBLL1 ZNF200 CHD7 FANCM DICER1 CTPS2 DST BRCA2 CTCF IRAK4 SNX10 KIF5C GNAS HERC2 TDP1 | 4.93e-06 | 892 | 153 | 18 | M18120 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | SATB2 NRCAM TEX2 DOCK9 CHD7 FBXL5 CEP68 DST SYNE2 KATNIP HERC2 | 5.40e-06 | 340 | 153 | 11 | M2012 |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 7.11e-06 | 224 | 153 | 9 | M2500 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ARID4B DYNC2I1 CEP350 BPTF FRA10AC1 PIEZO2 SYNE2 NEMF SNX10 HTATSF1 CDC5L MBD4 FYB1 TOP2B PCM1 | 7.41e-06 | 656 | 153 | 15 | M18979 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | DMXL2 FMR1 MAP7D3 PSMA1 COBLL1 PSMD2 PRPF6 DICER1 PRDM2 LRCH3 CEP350 ACSL4 CEP68 SIDT2 UPF2 CAPN7 SYNE2 LRBA TDP1 MBD4 PCM1 | 8.39e-06 | 1215 | 153 | 21 | M41122 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | FMR1 ARID4B HIPK1 FBXL5 CEP350 UPF2 CTCF CAPN7 NEMF HTATSF1 HERC2 MBD4 | 8.76e-06 | 429 | 153 | 12 | M29 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CASC3 DMXL2 NRCAM MAP1B ZNF652 COBLL1 CHD7 DICER1 GFPT1 FRA10AC1 DST CAPN7 SYNE2 PDZD8 KIF5C GNAS CDC5L PCM1 | 1.10e-05 | 946 | 153 | 18 | M39169 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TNIK SLC12A6 RGPD8 ARID4A HIPK1 ZDBF2 CHD7 USP16 DICER1 PRDM2 SEPSECS PDZD8 GNAS MAP4K4 RGPD5 | 1.13e-05 | 680 | 153 | 15 | M41089 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SATB2 MAP1B PTK2 WDR43 CEP350 BPTF DST UPF2 MICAL3 KIF5C CUX1 FILIP1L | 1.99e-05 | 466 | 153 | 12 | M13522 |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN | 2.40e-05 | 200 | 153 | 8 | M7302 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_DN | 2.40e-05 | 200 | 153 | 8 | M3154 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | 2.67e-05 | 203 | 153 | 8 | M9695 | |
| Coexpression | PATIL_LIVER_CANCER | DDX12P ARID4B MAP1B ZNF652 CHAF1A LAMA4 PRPF6 PTK2 DDX11 BPTF PIEZO2 RTCA SUPT16H MAP4K4 | 3.45e-05 | 660 | 153 | 14 | M1195 |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 3.49e-05 | 154 | 153 | 7 | M6824 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 5.62e-05 | 166 | 153 | 7 | M39026 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 6.46e-05 | 230 | 153 | 8 | M11563 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 9.92e-05 | 126 | 153 | 6 | M39132 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.14e-04 | 81 | 153 | 5 | M39253 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 1.43e-04 | 85 | 153 | 5 | M17423 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 1.44e-04 | 193 | 153 | 7 | M4961 | |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP | 1.59e-04 | 196 | 153 | 7 | M7562 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP | 1.64e-04 | 197 | 153 | 7 | M4504 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 1.64e-04 | 197 | 153 | 7 | M5480 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.69e-04 | 198 | 153 | 7 | M8624 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | TRPA1 RGPD8 VEZT MINK1 DYNC2I1 DAPK3 CNPY2 GFPT1 PTK2 ACSL4 CEP120 KCNJ2 MAP4K1 NEMF YLPM1 MBD4 FYB1 MAP4K4 TOP2B | 1.70e-04 | 1277 | 153 | 19 | MM1032 |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 1.74e-04 | 199 | 153 | 7 | M3257 | |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP | 1.74e-04 | 199 | 153 | 7 | M7798 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 1.80e-04 | 200 | 153 | 7 | M8090 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.80e-04 | 200 | 153 | 7 | M8618 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 1.80e-04 | 200 | 153 | 7 | M6090 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.80e-04 | 200 | 153 | 7 | M9258 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.90e-04 | 269 | 153 | 8 | M41203 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 1.98e-04 | 344 | 153 | 9 | M2239 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | NCAM1 FANCM DICER1 REXO1 WDR43 SEPSECS SLC12A4 CBX5 CAPN7 ZRANB2 SNX10 KIF5C GNAS XRCC6 | 2.17e-04 | 786 | 153 | 14 | M2388 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 2.28e-04 | 208 | 153 | 7 | M39233 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 2.92e-04 | 99 | 153 | 5 | M768 | |
| Coexpression | PALOMERO_GSI_SENSITIVITY_DN | 3.35e-04 | 5 | 153 | 2 | M14865 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | TRPA1 VEZT MINK1 DYNC2I1 DAPK3 CNPY2 GFPT1 PTK2 ACSL4 CEP120 KCNJ2 MAP4K1 NEMF YLPM1 MBD4 FYB1 MAP4K4 TOP2B | 3.40e-04 | 1239 | 153 | 18 | M1743 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | FMR1 ARID4B ARID4A PDAP1 PRPF6 CHD7 DICER1 BRCA2 SYNE2 NEMF SUPT16H KIF5C LRBA CUX1 TOP2B PCM1 | 8.70e-10 | 311 | 152 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | FMR1 ARID4A PDAP1 ZDBF2 PRPF6 CHD7 BRCA2 SYNE2 NEMF SUPT16H KIF5C PCM1 | 1.43e-08 | 192 | 152 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FMR1 ARID4B MAP7D3 NRCAM MAP1B ARID4A PDAP1 ZDBF2 PRPF6 CHD7 DICER1 SCAF4 ACSL4 BRCA2 SYNE2 NEMF SUPT16H MICAL3 KIF5C LRBA CCDC181 RIMS2 CUX1 TOP2B PCM1 | 3.68e-08 | 989 | 152 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NRCAM DNAH10 MAP1B CHAF1A PDAP1 DYNC2I1 ZDBF2 CHD7 FANCM CEP350 ACSL4 CTPS2 BRCA2 KCNJ2 SYNE2 NEMF KATNIP KIF5C LRBA RIMS2 FYB1 CUX1 TOP2B FILIP1L | 1.36e-07 | 983 | 152 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | CASC3 ARID4A PDAP1 DYNC2I1 PRPF6 CHD7 ACSL4 BRCA2 SYNE2 SUPT16H KIF5C | 1.42e-07 | 192 | 152 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TNIK SATB2 ARID4B ERCC6L ARID4A HIPK1 PDAP1 DYNC2I1 PRPF6 CHD7 FANCM LRCH3 CEP120 BRCA2 KCNJ2 MAP4K1 SYNE2 YLPM1 SUPT16H PDZD8 KIF5C LRBA NEXN THRAP3 TOP2B PCM1 FILIP1L | 2.47e-07 | 1252 | 152 | 27 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CASC3 ARID4A LAMA2 PDAP1 DYNC2I1 PRPF6 CHD7 ACSL4 ZFHX4 BRCA2 SYNE2 SUPT16H MICAL3 KIF5C FYB1 FILIP1L | 5.14e-07 | 492 | 152 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DMXL2 MAP1B ARID4A HIPK1 PDAP1 ZDBF2 PRPF6 CHD7 ACSL4 BRCA2 CAPN7 SYNE2 NEMF SUPT16H GPATCH11 MICAL3 KIF5C CCDC181 CUX1 TOP2B PCM1 | 5.16e-07 | 831 | 152 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | FMR1 MAP7D3 NRCAM MAP1B ARID4A PDAP1 ZDBF2 PRPF6 CHD7 BRCA2 SYNE2 NEMF SUPT16H KIF5C RIMS2 PCM1 | 6.03e-07 | 498 | 152 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | MAP1B PDAP1 DYNC2I1 ZDBF2 CHD7 ACSL4 BRCA2 SYNE2 NEMF KIF5C RIMS2 | 9.37e-07 | 232 | 152 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CASC3 ARID4B MAP1B ARID4A ZDBF2 PRPF6 CHD7 PRDM2 BPTF UPF2 CTCF SYNE2 YLPM1 PDZD8 KIF5C CDC5L RIMS2 | 1.33e-06 | 595 | 152 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ARID4B NRCAM MAP1B ERCC6L ARID4A PDAP1 DYNC2I1 ZDBF2 PRPF6 CHD7 FANCM USP16 DICER1 LRCH3 CEP350 BPTF CEP120 UPF2 BRCA2 SKAP1 SYNE2 NEMF SUPT16H KIF5C CDC5L THRAP3 CUX1 PCM1 | 1.48e-06 | 1459 | 152 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | SATB2 ARID4B ERCC6L MYH7B PDAP1 DYNC2I1 ZDBF2 PRPF6 CHD7 CNPY2 FANCM USP16 LRCH3 FRA10AC1 BRCA2 MAP4K1 NEMF SUPT16H KIF5C LRBA NEXN THRAP3 TOP2B PCM1 FILIP1L | 2.52e-06 | 1241 | 152 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SATB2 ARID4B ARID4A SYNE1 PDAP1 DYNC2I1 PRPF6 ZFHX4 BRCA2 KCNJ2 YLPM1 LRBA PCM1 FILIP1L | 2.86e-06 | 432 | 152 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | SATB2 ARID4B ERCC6L MYH7B PDAP1 DYNC2I1 CCRL2 ZDBF2 PRPF6 CHD7 CNPY2 FANCM USP16 LRCH3 FRA10AC1 BRCA2 MAP4K1 SKAP1 NEMF SUPT16H KIF5C LRBA NEXN THRAP3 TOP2B PCM1 FILIP1L | 5.21e-06 | 1468 | 152 | 27 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | MYLK MAP1B LAMA4 GFPT1 CEP350 DST ZFHX4 SUPT16H KIF5C HERC2 NEXN CUX1 TOP2B | 7.89e-06 | 408 | 152 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.00e-06 | 186 | 152 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.01e-05 | 69 | 152 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ARID4B NRCAM ERCC6L ARID4A PDAP1 DYNC2I1 ZDBF2 PRPF6 FANCM USP16 DICER1 LRCH3 CEP350 BPTF CEP120 UPF2 BRCA2 SYNE2 NEMF SUPT16H CDC5L THRAP3 CUX1 PCM1 | 1.01e-05 | 1257 | 152 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | PDAP1 DYNC2I1 FANCM CTPS2 BRCA2 KCNJ2 KATNIP LRBA TOP2B FILIP1L | 1.15e-05 | 246 | 152 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CASC3 DMXL2 ARID4A HIPK1 PDAP1 DYNC2I1 PRPF6 CHD7 ACSL4 BRCA2 CAPN7 SYNE2 SUPT16H GPATCH11 MICAL3 KIF5C CUX1 TOP2B | 1.25e-05 | 780 | 152 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SATB2 DNAH10 PDAP1 DYNC2I1 ZDBF2 PRPF6 CHD7 CNPY2 BRCA2 YLPM1 KIF5C LRBA PCM1 FILIP1L | 1.26e-05 | 492 | 152 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NRCAM DNAH10 MAP1B CHAF1A PDAP1 DYNC2I1 ZDBF2 CHD7 ACSL4 BRCA2 SYNE2 NEMF KIF5C RIMS2 | 1.29e-05 | 493 | 152 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAP1B PDAP1 DYNC2I1 NCAM1 ZDBF2 CHD7 CEP350 ACSL4 FRA10AC1 DST SYNE2 NEMF KIF5C RIMS2 CUX1 TOP2B | 1.93e-05 | 654 | 152 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 2.66e-05 | 166 | 152 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MAP1B PDAP1 ZDBF2 CHD7 FANCM USP16 PTK2 ACSL4 BRCA2 NEMF SUPT16H ZRANB2 MICAL3 THRAP3 | 2.98e-05 | 532 | 152 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | FMR1 MAP1B ARID4A PDAP1 ZDBF2 CHD7 SYNE2 SUPT16H KIF5C RIMS2 | 5.92e-05 | 298 | 152 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 5.94e-05 | 58 | 152 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.02e-05 | 194 | 152 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | CASC3 ARID4A LAMA2 PDAP1 DYNC2I1 PRPF6 CHD7 ACSL4 ZFHX4 BRCA2 SYNE2 SUPT16H MICAL3 RIC8A KIF5C LRBA MBD4 FYB1 FILIP1L | 8.15e-05 | 985 | 152 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CASC3 SATB2 ARID4B DNAH10 ARID4A SYNE1 PDAP1 DYNC2I1 PRPF6 CHD7 ZFHX4 BRCA2 KCNJ2 SYNE2 YLPM1 KIF5C LRBA PCM1 FILIP1L | 8.60e-05 | 989 | 152 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | NRCAM ERCC6L VEZT CHD7 FANCM DICER1 DDX11 CBX5 SKAP1 KIF5C MAP4K4 | 8.66e-05 | 376 | 152 | 11 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | SATB2 FMR1 SYNE1 LAMA2 PDAP1 LAMA4 DYNC2I1 FANCM CTPS2 ZFHX4 BRCA2 KCNJ2 LRBA FILIP1L | 1.22e-04 | 607 | 152 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.31e-04 | 328 | 152 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CASC3 ARID4B ARID4A PDAP1 DYNC2I1 PRPF6 CHD7 BPTF UPF2 BRCA2 SYNE2 YLPM1 KIF5C PCM1 | 1.76e-04 | 629 | 152 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.90e-04 | 165 | 152 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 1.97e-04 | 166 | 152 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 2.44e-04 | 78 | 152 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SATB2 FMR1 MAP7D3 NRCAM MAP1B ARID4A PDAP1 ZDBF2 CHD7 DNAAF9 FANCM BRCA2 KCNJ2 SYNE2 SUPT16H KIF5C LRBA RIMS2 | 2.50e-04 | 986 | 152 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.56e-04 | 291 | 152 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DMXL2 SATB2 FMR1 ERCC6L TEX2 PSMD2 FBXL5 FRA10AC1 TRANK1 BRCA2 SUPT16H MORC3 LRBA CCDC181 RIMS2 XRCC6 | 2.70e-04 | 820 | 152 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 2.72e-04 | 124 | 152 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | MORC1 DMXL2 FMR1 ERCC6L TEX2 PSMD2 FANCM WDR43 FBXL5 FRA10AC1 BRCA2 SUPT16H MORC3 RIMS2 FYB1 XRCC6 | 2.78e-04 | 822 | 152 | 16 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | SATB2 LAMA4 NCAM1 ZDBF2 CHD7 PIEZO2 ZFHX4 RIMS2 SMCR8 FYB1 CUX1 | 2.83e-04 | 431 | 152 | 11 | gudmap_developingKidney_e13.5_podocyte cells_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 3.20e-04 | 19 | 152 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TNIK MAP7D3 MAP1B DOCK9 LAMA4 CHD7 DNAAF9 RYR2 SIDT2 TNRC18 TRANK1 CTPS2 DST ZFHX4 SPIDR THRAP3 | 3.39e-04 | 837 | 152 | 16 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK9 LAMA4 CCRL2 DGKH CHD7 PTK2 PLEKHG1 PIEZO2 KCNJ2 MMRN2 MAP4K4 | 3.65e-04 | 444 | 152 | 11 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | SATB2 SYNE1 LAMA2 LAMA4 FANCM PIEZO2 CTPS2 ZFHX4 BRCA2 KCNJ2 KATNIP LRBA FILIP1L | 3.66e-04 | 596 | 152 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.73e-04 | 243 | 152 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100 | 3.84e-04 | 86 | 152 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100 | 3.84e-04 | 86 | 152 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.64e-04 | 137 | 152 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.01e-04 | 139 | 152 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 5.14e-04 | 255 | 152 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 5.25e-04 | 92 | 152 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_100 | 5.25e-04 | 92 | 152 | 5 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ARID4A PDAP1 CHD7 FANCM DST UPF2 BRCA2 NEMF SUPT16H MORC3 MAP4K4 | 5.76e-04 | 469 | 152 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | MAP1B ERCC6L LAMA4 GFPT1 RYR2 CEP350 SUPT16H HERC2 CUX1 TOP2B | 5.94e-04 | 397 | 152 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.43e-04 | 202 | 152 | 7 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.81e-04 | 204 | 152 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 6.94e-04 | 56 | 152 | 4 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 7.00e-04 | 98 | 152 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 7.67e-04 | 100 | 152 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ARID4B ARID4A PRPF6 CHD7 FANCM DICER1 RTF1 BPTF CEP120 UPF2 YLPM1 PCM1 | 7.67e-04 | 564 | 152 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.74e-04 | 151 | 152 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.02e-04 | 101 | 152 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_100 | 8.29e-04 | 26 | 152 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 8.34e-04 | 415 | 152 | 10 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | SATB2 DNAH10 SYNE1 PDAP1 DYNC2I1 CHD7 ZFHX4 BRCA2 KCNJ2 LRBA FILIP1L | 8.53e-04 | 492 | 152 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 9.17e-04 | 156 | 152 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TNIK SATB2 ARID4B SYNE1 LAMA2 PDAP1 LAMA4 DYNC2I1 PIEZO2 CTPS2 ZFHX4 BRCA2 KCNJ2 FILIP1L | 9.37e-04 | 744 | 152 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | SATB2 SYNE1 LAMA2 PDAP1 DYNC2I1 PRPF6 CNPY2 PIEZO2 CTPS2 ZFHX4 BRCA2 KCNJ2 YLPM1 LRBA FILIP1L | 9.73e-04 | 834 | 152 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_100 | 1.04e-03 | 7 | 152 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 1.09e-03 | 430 | 152 | 10 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | 1.13e-03 | 432 | 152 | 10 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.21e-03 | 225 | 152 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 1.22e-03 | 165 | 152 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | SATB2 NRCAM LAMA4 NCAM1 ZDBF2 CHD7 DDX11 PLEKHG1 PIEZO2 ZFHX4 RIMS2 SMCR8 FYB1 CUX1 TANGO6 | 1.25e-03 | 855 | 152 | 15 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | TNIK MYLK MAP1B LAMA4 RYR2 CEP350 ACSL4 ATP1B4 DST ZFHX4 KIF5C NEXN CUX1 FILIP1L | 1.33e-03 | 772 | 152 | 14 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#3_top-relative-expression-ranked_200 | 1.39e-03 | 8 | 152 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.39e-03 | 369 | 152 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | LAMA4 CCRL2 DGKH CHD7 PTK2 PLEKHG1 PIEZO2 KCNJ2 MMRN2 FYB1 MAP4K4 | 1.39e-03 | 523 | 152 | 11 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | LAMA4 CCRL2 DGKH CHD7 PTK2 PLEKHG1 PIEZO2 KCNJ2 MMRN2 FYB1 MAP4K4 | 1.39e-03 | 523 | 152 | 11 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.41e-03 | 298 | 152 | 8 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200 | 1.43e-03 | 170 | 152 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | MAP1B ARID4A ANKRD62 DYNC2I1 RTF1 CEP350 UPF2 NEMF RIMS2 NEXN PRRC2A | 9.30e-11 | 197 | 153 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-09 | 194 | 153 | 10 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-09 | 197 | 153 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-08 | 184 | 153 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-08 | 184 | 153 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-08 | 184 | 153 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.73e-08 | 186 | 153 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.99e-08 | 189 | 153 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-08 | 189 | 153 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.09e-08 | 190 | 153 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.09e-08 | 190 | 153 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.18e-08 | 191 | 153 | 9 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.18e-08 | 191 | 153 | 9 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-08 | 195 | 153 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.11e-08 | 199 | 153 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.25e-08 | 200 | 153 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-07 | 176 | 153 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 177 | 153 | 8 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 177 | 153 | 8 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.86e-07 | 177 | 153 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-07 | 179 | 153 | 8 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-07 | 179 | 153 | 8 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.21e-07 | 181 | 153 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.51e-07 | 184 | 153 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.72e-07 | 186 | 153 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.72e-07 | 186 | 153 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.72e-07 | 186 | 153 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.84e-07 | 187 | 153 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.95e-07 | 188 | 153 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.07e-07 | 189 | 153 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 189 | 153 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 189 | 153 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-07 | 190 | 153 | 8 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-07 | 190 | 153 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-07 | 190 | 153 | 8 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.33e-07 | 191 | 153 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-07 | 191 | 153 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.47e-07 | 192 | 153 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.47e-07 | 192 | 153 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.61e-07 | 193 | 153 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-07 | 193 | 153 | 8 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 194 | 153 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 194 | 153 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-07 | 195 | 153 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-07 | 195 | 153 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.90e-07 | 195 | 153 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-07 | 197 | 153 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-07 | 197 | 153 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-07 | 197 | 153 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-07 | 197 | 153 | 8 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-07 | 197 | 153 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.38e-07 | 198 | 153 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.55e-07 | 199 | 153 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.55e-07 | 199 | 153 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.55e-07 | 199 | 153 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-07 | 200 | 153 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.72e-07 | 200 | 153 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-07 | 200 | 153 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.72e-07 | 200 | 153 | 8 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-07 | 200 | 153 | 8 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-07 | 200 | 153 | 8 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.72e-07 | 200 | 153 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 200 | 153 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.72e-07 | 200 | 153 | 8 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-07 | 200 | 153 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 5.11e-07 | 138 | 153 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 157 | 153 | 7 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 157 | 153 | 7 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 169 | 153 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-06 | 171 | 153 | 7 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-06 | 171 | 153 | 7 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-06 | 177 | 153 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-06 | 177 | 153 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 3.02e-06 | 180 | 153 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-06 | 181 | 153 | 7 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 3.62e-06 | 185 | 153 | 7 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 186 | 153 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.89e-06 | 187 | 153 | 7 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.89e-06 | 187 | 153 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.03e-06 | 188 | 153 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-06 | 188 | 153 | 7 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-06 | 189 | 153 | 7 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.17e-06 | 189 | 153 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.32e-06 | 190 | 153 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-06 | 190 | 153 | 7 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-06 | 190 | 153 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 4.32e-06 | 190 | 153 | 7 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-06 | 190 | 153 | 7 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.47e-06 | 191 | 153 | 7 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 8.93e-07 | 199 | 151 | 10 | 6882_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.98e-06 | 184 | 151 | 9 | 2321_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 5.17e-06 | 190 | 151 | 9 | 4307_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 5.63e-06 | 192 | 151 | 9 | 4311_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 6.13e-06 | 194 | 151 | 9 | 1924_DN | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; PC3; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 5888_DN | |
| Drug | Thimerosal | COBLL1 B3GALNT2 NCAM1 PRPF6 CNPY2 USP16 PTK2 PRDM2 CEP350 FSIP2 ACSL4 FRA10AC1 SEPSECS DST BRCA2 CBX5 MAP4K1 SYNE2 SUPT16H HTATSF1 THRAP3 PCM1 | 1.42e-05 | 1199 | 151 | 22 | ctd:D013849 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.00e-05 | 182 | 151 | 8 | 3887_DN | |
| Drug | AC1L1IZ2 | 3.71e-05 | 304 | 151 | 10 | CID000004795 | |
| Drug | Alsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A | 3.78e-05 | 188 | 151 | 8 | 7078_DN | |
| Drug | AC1NSWD2 | 4.37e-05 | 2 | 151 | 2 | CID005318091 | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 6707_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 7128_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 2558_DN | |
| Drug | SC-58125; Up 200; 10uM; HL60; HG-U133A | 5.26e-05 | 197 | 151 | 8 | 542_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 6240_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; HL60; HG-U133A | 5.46e-05 | 198 | 151 | 8 | 1404_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 4601_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 4765_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; HL60; HG-U133A | 5.65e-05 | 199 | 151 | 8 | 1779_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 7261_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 5782_DN | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:0060535 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | TNIK SATB2 DOCK9 CHAF1A LAMA2 NCAM1 CHD7 DNAAF9 STRIP1 PLEKHG1 SEPSECS CEP120 LRRIQ1 CBX5 CDC5L MAP4K4 PRRC2A XRCC6 CUX1 TANGO6 | 1.23e-05 | 1345 | 147 | 20 | EFO_0010736 |
| Disease | epilepsy (implicated_via_orthology) | 1.84e-05 | 163 | 147 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Mood instability | 2.47e-05 | 2 | 147 | 2 | C2678248 | |
| Disease | Sex Cord-Stromal Tumor | 2.47e-05 | 2 | 147 | 2 | C0206724 | |
| Disease | diastolic blood pressure, systolic blood pressure | MAP1B NEK10 RYR2 WDR43 RTF1 CEP350 PIEZO2 CEP120 MMRN2 NEXN CUX1 PCM1 TANGO6 | 3.27e-05 | 670 | 147 | 13 | EFO_0006335, EFO_0006336 |
| Disease | Fragile X Syndrome | 7.37e-05 | 3 | 147 | 2 | C0016667 | |
| Disease | FRAXE Syndrome | 7.37e-05 | 3 | 147 | 2 | C0751157 | |
| Disease | FRAXA Syndrome | 7.37e-05 | 3 | 147 | 2 | C0751156 | |
| Disease | uveal melanoma (is_implicated_in) | 1.47e-04 | 4 | 147 | 2 | DOID:6039 (is_implicated_in) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.47e-04 | 4 | 147 | 2 | cv:CN293514 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.40e-04 | 111 | 147 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.44e-04 | 5 | 147 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.44e-04 | 5 | 147 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 3.65e-04 | 6 | 147 | 2 | cv:C0410189 | |
| Disease | pappalysin-1 measurement | 3.65e-04 | 6 | 147 | 2 | EFO_0802845 | |
| Disease | Congenital muscular dystrophy (disorder) | 3.65e-04 | 6 | 147 | 2 | C0699743 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 3.65e-04 | 6 | 147 | 2 | C0410189 | |
| Disease | synophrys measurement | 3.76e-04 | 68 | 147 | 4 | EFO_0007906 | |
| Disease | platelet component distribution width | SYNE1 DOCK9 COBLL1 NKX2-3 PSMD2 CEP68 SIDT2 TRANK1 GNAS FYB1 PRRC2A CUX1 | 4.16e-04 | 755 | 147 | 12 | EFO_0007984 |
| Disease | vital capacity | MYH7B SYNE1 LAMA2 ZSWIM2 CHD7 GFPT1 RYR2 DST CEP120 LRRIQ1 SKAP1 MICAL3 LRBA CDC5L MBD4 FILIP1L | 4.60e-04 | 1236 | 147 | 16 | EFO_0004312 |
| Disease | cortical thickness | TNIK SATB2 DOCK9 CHAF1A LAMA2 NCAM1 CHD7 DNAAF9 PLEKHG1 SEPSECS CEP120 LRRIQ1 YLPM1 MICAL3 CDC5L | 4.61e-04 | 1113 | 147 | 15 | EFO_0004840 |
| Disease | Ovarian Mucinous Adenocarcinoma | 4.92e-04 | 31 | 147 | 3 | C1335167 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.09e-04 | 7 | 147 | 2 | C0751337 | |
| Disease | pulse pressure measurement | MAP1B TEX2 NEK10 COBLL1 NCAM1 PLEKHG1 CEP68 PIEZO2 TRANK1 MLIP CEP120 ZFHX4 SKAP1 HYDIN XRCC6 PCM1 FILIP1L | 5.88e-04 | 1392 | 147 | 17 | EFO_0005763 |
| Disease | insulinoma (is_marker_for) | 6.77e-04 | 8 | 147 | 2 | DOID:3892 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | TNIK FAM53A COBLL1 NKX2-3 USP16 RYR2 BPTF TRANK1 MLIP CEP120 MICAL3 LRBA PRRC2A | 6.80e-04 | 914 | 147 | 13 | EFO_0004532 |
| Disease | ascending aortic diameter | 6.97e-04 | 140 | 147 | 5 | EFO_0021787 | |
| Disease | Nephroblastoma | 7.67e-04 | 36 | 147 | 3 | C0027708 | |
| Disease | Pituitary Adenoma | 8.67e-04 | 9 | 147 | 2 | C0032000 | |
| Disease | Back pain | 9.55e-04 | 87 | 147 | 4 | HP_0003418 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.01e-03 | 152 | 147 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | octadecanedioate measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0021056 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.08e-03 | 10 | 147 | 2 | C1631597 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0008321 | |
| Disease | colorectal cancer (is_marker_for) | 1.16e-03 | 157 | 147 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Atrial Fibrillation | 1.27e-03 | 160 | 147 | 5 | C0004238 | |
| Disease | Jeune thoracic dystrophy | 1.32e-03 | 11 | 147 | 2 | C0265275 | |
| Disease | Tachycardia, Ventricular | 1.32e-03 | 11 | 147 | 2 | C0042514 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.49e-03 | 166 | 147 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | Endogenous depression | 1.57e-03 | 46 | 147 | 3 | C0011573 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | outer ear morphology trait | 1.57e-03 | 12 | 147 | 2 | EFO_0007664 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 1.85e-03 | 13 | 147 | 2 | EFO_0004776 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.85e-03 | 13 | 147 | 2 | C0036996 | |
| Disease | Intellectual Disability | 1.86e-03 | 447 | 147 | 8 | C3714756 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.89e-03 | 49 | 147 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Unipolar Depression | 1.95e-03 | 259 | 147 | 6 | C0041696 | |
| Disease | forced expiratory volume | SYNE1 DOCK9 RYR2 DST CEP120 SKAP1 MICAL3 CDC5L MBD4 NEXN TOP2B | 2.06e-03 | 789 | 147 | 11 | EFO_0004314 |
| Disease | skin melanoma (is_implicated_in) | 2.16e-03 | 14 | 147 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | Saldino-Noonan Syndrome | 2.16e-03 | 14 | 147 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.16e-03 | 14 | 147 | 2 | C0024507 | |
| Disease | non-melanoma skin carcinoma | 2.18e-03 | 265 | 147 | 6 | EFO_0009260 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | MORC1 ARID4A MINK1 LAMA2 NCAM1 CHD7 PTK2 RYR2 SCAF4 BPTF CUX1 | 2.31e-03 | 801 | 147 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 2.48e-03 | 15 | 147 | 2 | EFO_0004611, EFO_0005658 | |
| Disease | Small cell carcinoma of lung | 2.49e-03 | 54 | 147 | 3 | C0149925 | |
| Disease | Metastatic melanoma | 2.49e-03 | 54 | 147 | 3 | C0278883 | |
| Disease | Hypermetropia, Myopia | 2.62e-03 | 189 | 147 | 5 | HP_0000540, HP_0000545 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 2.63e-03 | 55 | 147 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | triglycerides in LDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022320 | |
| Disease | Bipolar Disorder | 2.78e-03 | 477 | 147 | 8 | C0005586 | |
| Disease | free androgen index | 2.78e-03 | 374 | 147 | 7 | EFO_0007005 | |
| Disease | infant expressive language ability | 2.83e-03 | 16 | 147 | 2 | EFO_0006316 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1 measurement | 2.83e-03 | 16 | 147 | 2 | EFO_0008062 | |
| Disease | body fat percentage | 3.19e-03 | 488 | 147 | 8 | EFO_0007800 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.19e-03 | 17 | 147 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.19e-03 | 17 | 147 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Myopia | 3.26e-03 | 385 | 147 | 7 | HP_0000545 | |
| Disease | atopic asthma | 3.27e-03 | 199 | 147 | 5 | EFO_0010638 | |
| Disease | FEV/FEC ratio | FRAS1 DOCK9 NCAM1 MSL1 PTK2 DST CTCF SKAP1 SYNE2 YLPM1 MICAL3 NEXN CUX1 TOP2B | 3.38e-03 | 1228 | 147 | 14 | EFO_0004713 |
| Disease | triglycerides in small VLDL measurement | 3.53e-03 | 61 | 147 | 3 | EFO_0022145 | |
| Disease | Tachycardia | 3.58e-03 | 18 | 147 | 2 | C0039231 | |
| Disease | Bone marrow hypocellularity | 3.58e-03 | 18 | 147 | 2 | C1855710 | |
| Disease | Tachyarrhythmia | 3.58e-03 | 18 | 147 | 2 | C0080203 | |
| Disease | phospholipids in large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022169 | |
| Disease | Arsenic Induced Polyneuropathy | 3.70e-03 | 62 | 147 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 3.70e-03 | 62 | 147 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 3.70e-03 | 62 | 147 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 3.70e-03 | 62 | 147 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 3.70e-03 | 62 | 147 | 3 | C0274862 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 3.79e-03 | 206 | 147 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.99e-03 | 19 | 147 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | triglyceride measurement, body mass index | 3.99e-03 | 19 | 147 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Cardiomyopathies | 4.13e-03 | 130 | 147 | 4 | C0878544 | |
| Disease | age at menopause | 4.15e-03 | 302 | 147 | 6 | EFO_0004704 | |
| Disease | irritable bowel syndrome | 4.25e-03 | 131 | 147 | 4 | EFO_0000555 | |
| Disease | asthma | 4.50e-03 | 751 | 147 | 10 | MONDO_0004979 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.60e-03 | 67 | 147 | 3 | C3463824 | |
| Disease | joint damage measurement | 4.79e-03 | 68 | 147 | 3 | EFO_0005413 | |
| Disease | triglyceride measurement, body fat percentage | 4.86e-03 | 21 | 147 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Joubert syndrome 1 | 4.86e-03 | 21 | 147 | 2 | C4551568 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKNEEKTAEDYSVDE | 531 | O60488 | |
| IEVLSEDTDYEEDEV | 786 | Q4LE39 | |
| EKEDYSDRTISDEDE | 6 | Q8NEM8 | |
| EYDVLIEGELESDEA | 11 | O00421 | |
| ELEEREIDDTYIEDA | 501 | Q99459 | |
| EIDDTYIEDAADVDA | 506 | Q99459 | |
| NDTENKDVDDDYETA | 496 | P29374 | |
| EEGKDVDVSVYDFEE | 216 | P49711 | |
| SSSSEDEEEYVVEKV | 11 | P45973 | |
| KSEEEVESDDEYLAL | 471 | Q76N32 | |
| DYADGSEDKVVEVAE | 216 | P05067 | |
| QEDREDEEEKADYVT | 151 | Q9BWW8 | |
| TKYDEETTAKADEIE | 216 | P39880 | |
| KTSEDDELPYSDDEN | 386 | A6NC57 | |
| IGEEYDRESKSSDDV | 2701 | Q8TDJ6 | |
| DEAYDTTDSLLEENK | 241 | P20930 | |
| TKLLDYEVDSDEEWE | 591 | Q13111 | |
| KYEEELDLHDEEETS | 721 | Q9UPY3 | |
| VNKVVYDDHESEEEE | 121 | Q12830 | |
| AEDAEVTKAFEEDIE | 2536 | Q9P2D1 | |
| ISSDYSLEEIDEKEE | 411 | Q53SF7 | |
| YLADEEEEAEEEARV | 31 | Q9UN42 | |
| KAEYVLIVDSEGEDE | 126 | Q5VWP3 | |
| EKDDDAYKTEDSDDI | 1021 | Q99666 | |
| EKDDDAYKTEDSDDI | 1021 | O14715 | |
| DDEEDVSSKVEKAYV | 81 | Q0ZGT2 | |
| YENEVALTSKEEDDS | 376 | P63252 | |
| EETDSDVEYISETKI | 626 | Q86VD1 | |
| SEEEGKALEEEEKYE | 446 | Q96GW7 | |
| KDETEYEYSGSEEEE | 316 | O95819 | |
| EVSDDDEKEPEVDYR | 1436 | Q15746 | |
| DYIDSCTAEEEEAEV | 376 | Q96II8 | |
| PFADDVEDTYDDKTE | 1521 | Q7RTP6 | |
| VEDTYDDKTEDSSLQ | 1526 | Q7RTP6 | |
| DSEYEEEEEFEIALA | 2756 | Q86XX4 | |
| SSETGDYEEKAETEE | 936 | P46821 | |
| PTEDEESAKAEADAY | 971 | P46821 | |
| ESSEDEGEYEEVRKD | 746 | O60524 | |
| VKKEDSDDSLVDYGE | 1246 | Q92823 | |
| KSLDSDESEDEEDDY | 56 | Q13442 | |
| ITIRSDTDEEEDNKY | 906 | Q86Z02 | |
| ADTVSDEYSDEEVVE | 2516 | O95714 | |
| EIKELYSESDETFDQ | 411 | Q9H8L6 | |
| DKEDESEIEEYSCAV | 2336 | Q03001 | |
| QKDCSSDEYDSIEED | 196 | O60303 | |
| ESDDDVLLVAAYEAE | 51 | Q8IYD8 | |
| AELSEEDAEYVSSDE | 1516 | Q8IYD8 | |
| EKEETDLENARADAY | 356 | Q8WVS4 | |
| KEEEETKFIYSEDDI | 4526 | Q5CZC0 | |
| SIRDSEDELFEKAEE | 4646 | Q5CZC0 | |
| DDTEYEKEVLGSDSE | 5591 | Q5CZC0 | |
| YIKEERDSDEDEVVL | 6656 | Q5CZC0 | |
| ETDEKSQEEEFDEYF | 296 | Q70Z53 | |
| DEQDAYVEAEVKSEA | 81 | A7E2Y1 | |
| KDEETEESEYDSEHE | 526 | Q15154 | |
| LENAEKDTYSEVDDE | 891 | Q6ZWH5 | |
| KDTYSEVDDELDISD | 896 | Q6ZWH5 | |
| SVYKGDDDDEDVIIL | 566 | Q14149 | |
| ISKYTDDTEEDLDNE | 1116 | Q8NEN9 | |
| DSEGETYEDIEASKE | 456 | O15117 | |
| EDVEALAAIYEEKEA | 351 | O43293 | |
| ESEELSEDKEEFVGY | 356 | Q96JB8 | |
| ETDLEIEDDEKFFTT | 66 | Q0VAA2 | |
| FLDKSIVEEEEDDDY | 1096 | P50851 | |
| ISYDLEEEEEDTERV | 606 | P24043 | |
| GKDLEFTIYDDDDVS | 216 | P25786 | |
| ESGEEELVLAEYESD | 191 | Q96FC9 | |
| EDEDDLEEEHITKIY | 216 | Q96FC9 | |
| YDSTETDESKEEAKD | 656 | Q86XP1 | |
| YETEEREETELSEKI | 286 | Q68DK7 | |
| AIKNEESDEEYREID | 1421 | Q96JM4 | |
| EDTYEKVFDDESDEK | 631 | O43719 | |
| ESDEKEDEEYADEKG | 641 | O43719 | |
| KEYIVDDEDVESRDE | 336 | Q9UQ26 | |
| YIAEKQKDDEAEEAE | 181 | Q8IZU1 | |
| DTDSKKSEEYEDDFE | 6 | Q5TID7 | |
| TIKEEDTDYGILDEA | 1811 | Q9P2D7 | |
| ESDEVEVYSRANEKE | 61 | Q06787 | |
| KTYLEEEEDEESLEK | 1971 | Q4G0P3 | |
| EKEQDEDEYKSEDLS | 226 | Q8N954 | |
| EEGEYSEEENSKVEL | 101 | O15234 | |
| HVYEVDEEVDKDEDA | 151 | Q9BZ29 | |
| LEDEVYETVVDTSEE | 291 | P51587 | |
| DEKENVEDAIELYTE | 101 | Q9Y6W3 | |
| KDDATESEVESLQYD | 396 | Q8N960 | |
| EDDLMKTEDEYETLE | 646 | Q4L180 | |
| EDALLKEESSIYDDI | 306 | Q8NCR0 | |
| ACESIVEEYEDELIE | 136 | Q9Y2B0 | |
| ESGEEELVLAEYESD | 191 | A8MPP1 | |
| EFDYETESETESEIE | 106 | O95467 | |
| TEEEDNLYAEASEKL | 2701 | Q5VT06 | |
| SGEEELVLAEYESDE | 211 | Q92771 | |
| YESDEEKKVASGVDE | 221 | Q92771 | |
| EYEDEEAAEEFKITS | 136 | Q5TEA3 | |
| EKYEDTFLESEEIGT | 346 | O95243 | |
| TTKNETSDEYAELEE | 196 | Q8TDB4 | |
| YEEAEADNEESDKDS | 741 | Q8IWC1 | |
| EEIEDEEKTIEDYID | 401 | Q9NWZ3 | |
| YSVDEKSDKEAEVSE | 186 | Q9UKA1 | |
| LSEEGEEEEETYSQK | 16 | Q8IVF4 | |
| EEEEETYSQKVESVD | 21 | Q8IVF4 | |
| GSDEDEETETYQEKV | 1031 | Q9UHW9 | |
| DYDDEPEAVEESKKE | 266 | O95104 | |
| KNDLEDYDADSDFEV | 1331 | Q92736 | |
| ETDENETLDYEEFVK | 4071 | Q92736 | |
| EDEEDEGEKLSYLNS | 61 | Q8TAU0 | |
| VEESSGEASKYTEED | 1131 | Q2NKX8 | |
| SKEEEELNDSSEELY | 1256 | Q13029 | |
| EEEENTDYLTDSNKE | 1071 | Q9HAU5 | |
| ELVDEEADEAYELLS | 441 | Q16363 | |
| KEETEYEYSGSEEED | 316 | Q8N4C8 | |
| DEDYSLDEIHTEVSK | 406 | Q9UKT6 | |
| KQLSESSDDDYDDVD | 371 | Q92918 | |
| LKTSEVYSDDEEEEE | 306 | Q92541 | |
| VYSDDEEEEEDDKSS | 311 | Q92541 | |
| DVDYSALEKEVDFDS | 596 | Q8N1G1 | |
| NTVEEDEEETKYEIF | 131 | Q5MJ70 | |
| EEDDYDTLTDIDSDK | 406 | Q8NBJ9 | |
| EVKYFAESDEEEDDV | 1606 | Q02880 | |
| KLTLEEDLEYEEEEA | 436 | Q9BRC7 | |
| YEKTEDESFKDTAQE | 2801 | Q8NF91 | |
| YLAAVEEEVEESSVK | 4111 | Q8WXH0 | |
| LESKGYDFESETDTE | 136 | Q06210 | |
| VAGISTEEKEKYDEE | 406 | O60282 | |
| KDDEEADAIYAALDK | 96 | O94906 | |
| ELSEDVEEYEDLTEI | 306 | Q13200 | |
| VSETDDYAEIIDEED | 391 | Q05397 | |
| IYDDVDLSEKESKDE | 586 | Q5VWT5 | |
| EEVDYTEKLKFSDEE | 331 | P48634 | |
| VAEYKDEELLTESEE | 686 | Q9UPW6 | |
| DPYKADDSREEEEEN | 371 | Q5VSL9 | |
| EESDYSKESLGSEEE | 971 | Q9Y5B9 | |
| SEDEDTDTDEYKEAK | 436 | Q9NPQ8 | |
| YSDEEDESAVGADKI | 966 | Q9UP95 | |
| EEYKEVEVTELSSFD | 436 | Q8TEV9 | |
| QEEDDEKYIFSDDSS | 256 | P13591 | |
| YNTDSEEDEEFLKDE | 1731 | O15417 | |
| DAYEVVESSSDEVDK | 546 | O94827 | |
| HRLKEEEDEYETSGE | 136 | Q9NUW8 | |
| SYYKTEGDEEAEEEQ | 6 | P12956 | |
| YIDSIDLEKITETED | 336 | Q9NRF8 | |
| KDETEYEYSGSEEEE | 316 | Q9UKE5 | |
| YKDEDDDAQDESQTE | 2291 | Q86UP3 | |
| KAEEYTEETEEREES | 791 | Q9Y2W1 | |
| VYEDVPDDTEDFKES | 21 | O75762 | |
| EDQDSEEEKDNDSYI | 411 | Q9Y5T5 | |
| ILEYSSDSEKEDDLE | 181 | Q14159 | |
| SEDEEDAAKDTYIIE | 341 | O00442 | |
| YDEIETEAVLAIDDD | 526 | Q93063 | |
| EGEKIDSEEALIYEE | 166 | Q9H5I5 | |
| EVAVYEEETVDLESK | 806 | Q9HCK1 | |
| IKEAISDEDEDEALY | 551 | Q9C0B7 | |
| SDEDEDEALYQKVSS | 556 | Q9C0B7 | |
| EEGKKENDIDYDSES | 161 | Q9Y5X0 | |
| EKKDAEEEESELGYI | 2026 | P49750 | |
| PVENEDYREKSSDDD | 171 | P98182 | |
| EDEDEDDADLSKYNL | 171 | O95218 | |
| EEDGYIKQKEIDSED | 131 | Q8NEG5 | |
| SKESDDNYDKTEDVD | 466 | Q9HD40 | |
| KETDGDEDDYVEIKS | 1271 | Q9ULL1 | |
| DEDDYVEIKSEEDES | 1276 | Q9ULL1 | |
| YVDDIDIDSDFRKDD | 546 | Q9HBM0 | |
| AEVDGDYSEEDKAVE | 1251 | O15050 | |
| VSKEDEEFCELYTED | 411 | Q8IWB9 | |
| LYTEDFDLETEGESK | 421 | Q8IWB9 | |
| DDTEEEEEEVSYKRE | 101 | Q9Y2D9 | |
| EEKEETYDDIDGFDS | 226 | Q86WV1 | |
| KLVYEEESSEEESDD | 596 | Q15061 | |
| SEEDYVEEKESEKCV | 11 | A6NNM8 | |
| NYEDDDEDDTPVKTV | 306 | Q6NSI3 |